




Analysis Type:	PANTHER Overrepresentation Test (Released 20200728)
Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.4081749 Released 2020-10-09
Analyzed List:	human_orthologs_for_go_enrichment.txt (Homo sapiens)	There are duplicate IDs in the file. The unique set of IDs will be used.
Reference List:	Homo sapiens (all genes in database)
Test Type:	FISHER
Correction:	FDR
GO biological process complete	Homo sapiens - REFLIST (20851)	human_orthologs_for_go_enrichment.txt (3154)	human_orthologs_for_go_enrichment.txt (expected)	human_orthologs_for_go_enrichment.txt (over/under)	human_orthologs_for_go_enrichment.txt (fold Enrichment)	human_orthologs_for_go_enrichment.txt (raw P-value)	human_orthologs_for_go_enrichment.txt (FDR)
drug transmembrane transport (GO:0006855)	8	8	1.21	+	6.61	4.24E-04	6.89E-03
monoterpenoid metabolic process (GO:0016098)	6	6	.91	+	6.61	2.33E-03	2.97E-02
succinate transmembrane transport (GO:0071422)	7	7	1.06	+	6.61	9.88E-04	1.43E-02
dehydroascorbic acid transport (GO:0070837)	7	7	1.06	+	6.61	9.88E-04	1.43E-02
ADP transport (GO:0015866)	7	7	1.06	+	6.61	9.88E-04	1.43E-02
succinate transport (GO:0015744)	7	7	1.06	+	6.61	9.88E-04	1.43E-02
ethanol catabolic process (GO:0006068)	12	11	1.82	+	6.06	5.83E-05	1.20E-03
drug transport (GO:0015893)	10	9	1.51	+	5.95	3.07E-04	5.19E-03
omega-hydroxylase P450 pathway (GO:0097267)	9	8	1.36	+	5.88	7.08E-04	1.08E-02
alditol catabolic process (GO:0019405)	8	7	1.21	+	5.78	1.64E-03	2.22E-02
formation of cytoplasmic translation initiation complex (GO:0001732)	16	14	2.42	+	5.78	8.14E-06	2.10E-04
ribosome disassembly (GO:0032790)	8	7	1.21	+	5.78	1.64E-03	2.21E-02
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299)	8	7	1.21	+	5.78	1.64E-03	2.21E-02
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267)	8	7	1.21	+	5.78	1.64E-03	2.21E-02
malate metabolic process (GO:0006108)	8	7	1.21	+	5.78	1.64E-03	2.21E-02
acetyl-CoA biosynthetic process from pyruvate (GO:0006086)	8	7	1.21	+	5.78	1.64E-03	2.21E-02
pre-replicative complex assembly (GO:0036388)	8	7	1.21	+	5.78	1.64E-03	2.20E-02
nucleotide transmembrane transport (GO:1901679)	15	13	2.27	+	5.73	1.84E-05	4.25E-04
primary alcohol catabolic process (GO:0034310)	15	13	2.27	+	5.73	1.84E-05	4.24E-04
ethanol metabolic process (GO:0006067)	21	18	3.18	+	5.67	5.13E-07	1.68E-05
dolichyl diphosphate biosynthetic process (GO:0006489)	7	6	1.06	+	5.67	3.84E-03	4.51E-02
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)	7	6	1.06	+	5.67	3.84E-03	4.51E-02
aminophospholipid transport (GO:0015917)	7	6	1.06	+	5.67	3.84E-03	4.50E-02
choline transport (GO:0015871)	7	6	1.06	+	5.67	3.84E-03	4.50E-02
ornithine transport (GO:0015822)	7	6	1.06	+	5.67	3.84E-03	4.50E-02
lipid hydroxylation (GO:0002933)	7	6	1.06	+	5.67	3.84E-03	4.49E-02
dolichyl diphosphate metabolic process (GO:0046465)	7	6	1.06	+	5.67	3.84E-03	4.49E-02
glycerol catabolic process (GO:0019563)	7	6	1.06	+	5.67	3.84E-03	4.49E-02
purine-containing compound transmembrane transport (GO:0072530)	19	16	2.87	+	5.57	2.58E-06	7.33E-05
double-strand break repair via break-induced replication (GO:0000727)	12	10	1.82	+	5.51	2.16E-04	3.79E-03
epoxygenase P450 pathway (GO:0019373)	21	17	3.18	+	5.35	1.83E-06	5.34E-05
phosphatidylethanolamine biosynthetic process (GO:0006646)	15	12	2.27	+	5.29	6.62E-05	1.35E-03
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	15	12	2.27	+	5.29	6.62E-05	1.34E-03
endonucleolytic cleavage involved in rRNA processing (GO:0000478)	15	12	2.27	+	5.29	6.62E-05	1.34E-03
positive regulation of telomerase RNA localization to Cajal body (GO:1904874)	15	12	2.27	+	5.29	6.62E-05	1.34E-03
IRES-dependent viral translational initiation (GO:0075522)	10	8	1.51	+	5.29	1.13E-03	1.61E-02
hydrocarbon metabolic process (GO:0120252)	10	8	1.51	+	5.29	1.13E-03	1.60E-02
positive regulation of establishment of protein localization to telomere (GO:1904851)	10	8	1.51	+	5.29	1.13E-03	1.60E-02
protein folding in endoplasmic reticulum (GO:0034975)	10	8	1.51	+	5.29	1.13E-03	1.60E-02
isoprenoid catabolic process (GO:0008300)	10	8	1.51	+	5.29	1.13E-03	1.60E-02
vitamin catabolic process (GO:0009111)	14	11	2.12	+	5.19	1.49E-04	2.76E-03
CDP-diacylglycerol metabolic process (GO:0046341)	14	11	2.12	+	5.19	1.49E-04	2.75E-03
protein retention in ER lumen (GO:0006621)	9	7	1.36	+	5.14	2.59E-03	3.23E-02
doxorubicin metabolic process (GO:0044598)	9	7	1.36	+	5.14	2.59E-03	3.22E-02
daunorubicin metabolic process (GO:0044597)	9	7	1.36	+	5.14	2.59E-03	3.22E-02
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	9	7	1.36	+	5.14	2.59E-03	3.22E-02
DNA topological change (GO:0006265)	9	7	1.36	+	5.14	2.59E-03	3.22E-02
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	9	7	1.36	+	5.14	2.59E-03	3.21E-02
polyketide metabolic process (GO:0030638)	9	7	1.36	+	5.14	2.59E-03	3.21E-02
peptidyl-arginine omega-N-methylation (GO:0035247)	9	7	1.36	+	5.14	2.59E-03	3.21E-02
spliceosomal tri-snRNP complex assembly (GO:0000244)	13	10	1.97	+	5.09	3.37E-04	5.64E-03
quaternary ammonium group transport (GO:0015697)	13	10	1.97	+	5.09	3.37E-04	5.64E-03
CDP-diacylglycerol biosynthetic process (GO:0016024)	13	10	1.97	+	5.09	3.37E-04	5.63E-03
midbody abscission (GO:0061952)	17	13	2.57	+	5.06	4.56E-05	9.64E-04
exogenous drug catabolic process (GO:0042738)	25	19	3.78	+	5.02	8.87E-07	2.76E-05
ethanol oxidation (GO:0006069)	12	9	1.82	+	4.96	7.62E-04	1.15E-02
fat-soluble vitamin catabolic process (GO:0042363)	12	9	1.82	+	4.96	7.62E-04	1.15E-02
pyrimidine-containing compound transmembrane transport (GO:0072531)	12	9	1.82	+	4.96	7.62E-04	1.15E-02
cytoplasmic translation (GO:0002181)	75	56	11.34	+	4.94	5.13E-17	5.18E-15
cytoplasmic translational initiation (GO:0002183)	31	23	4.69	+	4.90	8.70E-08	3.23E-06
drug catabolic process (GO:0042737)	27	20	4.08	+	4.90	6.12E-07	1.98E-05
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	96	71	14.52	+	4.89	5.04E-21	5.97E-19
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)	23	17	3.48	+	4.89	4.34E-06	1.18E-04
translational initiation (GO:0006413)	145	107	21.93	+	4.88	6.22E-31	1.35E-28
purine nucleotide transport (GO:0015865)	38	28	5.75	+	4.87	3.93E-09	1.88E-07
protein refolding (GO:0042026)	19	14	2.87	+	4.87	3.12E-05	6.87E-04
pentose metabolic process (GO:0019321)	15	11	2.27	+	4.85	2.28E-04	3.97E-03
adenine nucleotide transport (GO:0051503)	37	27	5.60	+	4.82	8.59E-09	3.84E-07
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	37	27	5.60	+	4.82	8.59E-09	3.83E-07
purine ribonucleotide transport (GO:0015868)	37	27	5.60	+	4.82	8.59E-09	3.82E-07
dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	22	16	3.33	+	4.81	9.58E-06	2.42E-04
nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	22	16	3.33	+	4.81	9.58E-06	2.42E-04
regulation of establishment of protein localization to telomere (GO:0070203)	11	8	1.66	+	4.81	1.73E-03	2.30E-02
positive regulation of protein localization to Cajal body (GO:1904871)	11	8	1.66	+	4.81	1.73E-03	2.30E-02
regulation of protein localization to Cajal body (GO:1904869)	11	8	1.66	+	4.81	1.73E-03	2.30E-02
peptidyl-arginine N-methylation (GO:0035246)	11	8	1.66	+	4.81	1.73E-03	2.30E-02
L-ascorbic acid metabolic process (GO:0019852)	11	8	1.66	+	4.81	1.73E-03	2.29E-02
regulation of telomerase RNA localization to Cajal body (GO:1904872)	18	13	2.72	+	4.77	6.92E-05	1.39E-03
late endosome to vacuole transport (GO:0045324)	25	18	3.78	+	4.76	2.96E-06	8.33E-05
ATP transport (GO:0015867)	32	23	4.84	+	4.75	1.31E-07	4.72E-06
mitotic cytokinetic process (GO:1902410)	21	15	3.18	+	4.72	2.11E-05	4.83E-04
nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)	35	25	5.29	+	4.72	4.10E-08	1.62E-06
basic amino acid transmembrane transport (GO:1990822)	14	10	2.12	+	4.72	5.10E-04	8.12E-03
cotranslational protein targeting to membrane (GO:0006613)	101	72	15.28	+	4.71	1.18E-20	1.37E-18
basic amino acid transport (GO:0015802)	17	12	2.57	+	4.67	1.53E-04	2.81E-03
protein depalmitoylation (GO:0002084)	10	7	1.51	+	4.63	3.91E-03	4.56E-02
DNA replication-dependent nucleosome assembly (GO:0006335)	10	7	1.51	+	4.63	3.91E-03	4.56E-02
ESCRT III complex disassembly (GO:1904903)	10	7	1.51	+	4.63	3.91E-03	4.56E-02
protein deneddylation (GO:0000338)	10	7	1.51	+	4.63	3.91E-03	4.55E-02
ESCRT complex disassembly (GO:1904896)	10	7	1.51	+	4.63	3.91E-03	4.55E-02
aminoglycoside antibiotic metabolic process (GO:0030647)	10	7	1.51	+	4.63	3.91E-03	4.55E-02
DNA replication-dependent nucleosome organization (GO:0034723)	10	7	1.51	+	4.63	3.91E-03	4.54E-02
glyoxylate metabolic process (GO:0046487)	10	7	1.51	+	4.63	3.91E-03	4.54E-02
protein targeting to ER (GO:0045047)	113	79	17.09	+	4.62	3.78E-22	4.76E-20
nucleotide transport (GO:0006862)	43	30	6.50	+	4.61	2.76E-09	1.37E-07
exonucleolytic catabolism of deadenylated mRNA (GO:0043928)	33	23	4.99	+	4.61	1.95E-07	6.91E-06
nucleotide-excision repair, DNA damage recognition (GO:0000715)	23	16	3.48	+	4.60	1.43E-05	3.43E-04
branched-chain amino acid catabolic process (GO:0009083)	23	16	3.48	+	4.60	1.43E-05	3.42E-04
proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	23	16	3.48	+	4.60	1.43E-05	3.41E-04
aldehyde catabolic process (GO:0046185)	13	9	1.97	+	4.58	1.14E-03	1.61E-02
lysine metabolic process (GO:0006553)	13	9	1.97	+	4.58	1.14E-03	1.61E-02
protein neddylation (GO:0045116)	13	9	1.97	+	4.58	1.14E-03	1.61E-02
positive regulation of protein localization to chromosome, telomeric region (GO:1904816)	13	9	1.97	+	4.58	1.14E-03	1.61E-02
nucleotide-excision repair, preincision complex assembly (GO:0006294)	29	20	4.39	+	4.56	1.36E-06	4.06E-05
DNA strand elongation involved in DNA replication (GO:0006271)	19	13	2.87	+	4.52	1.03E-04	1.96E-03
establishment of protein localization to endoplasmic reticulum (GO:0072599)	117	80	17.70	+	4.52	5.60E-22	6.99E-20
protein import into peroxisome membrane (GO:0045046)	22	15	3.33	+	4.51	3.13E-05	6.87E-04
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	121	82	18.30	+	4.48	2.58E-22	3.36E-20
S phase (GO:0051320)	65	44	9.83	+	4.48	1.25E-12	9.03E-11
mitotic S phase (GO:0000084)	65	44	9.83	+	4.48	1.25E-12	8.99E-11
tricarboxylic acid cycle (GO:0006099)	34	23	5.14	+	4.47	2.86E-07	9.93E-06
lysine catabolic process (GO:0006554)	12	8	1.82	+	4.41	2.55E-03	3.19E-02
azole transmembrane transport (GO:0045117)	12	8	1.82	+	4.41	2.55E-03	3.19E-02
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	12	8	1.82	+	4.41	2.55E-03	3.19E-02
nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)	21	14	3.18	+	4.41	6.83E-05	1.38E-03
nucleotide-excision repair, preincision complex stabilization (GO:0006293)	21	14	3.18	+	4.41	6.83E-05	1.37E-03
cleavage involved in rRNA processing (GO:0000469)	27	18	4.08	+	4.41	6.43E-06	1.70E-04
regulation of establishment of protein localization to chromosome (GO:0070202)	12	8	1.82	+	4.41	2.55E-03	3.18E-02
mitotic DNA replication (GO:1902969)	12	8	1.82	+	4.41	2.55E-03	3.18E-02
positive regulation of viral release from host cell (GO:1902188)	15	10	2.27	+	4.41	7.51E-04	1.14E-02
regulation of mitotic spindle assembly (GO:1901673)	18	12	2.72	+	4.41	2.25E-04	3.92E-03
fructose metabolic process (GO:0006000)	15	10	2.27	+	4.41	7.51E-04	1.14E-02
peptidyl-serine dephosphorylation (GO:0070262)	15	10	2.27	+	4.41	7.51E-04	1.14E-02
ribosomal large subunit assembly (GO:0000027)	30	20	4.54	+	4.41	1.99E-06	5.80E-05
retinal metabolic process (GO:0042574)	15	10	2.27	+	4.41	7.51E-04	1.14E-02
peroxisomal membrane transport (GO:0015919)	29	19	4.39	+	4.33	4.30E-06	1.17E-04
global genome nucleotide-excision repair (GO:0070911)	26	17	3.93	+	4.32	1.39E-05	3.35E-04
glutamine metabolic process (GO:0006541)	23	15	3.48	+	4.31	4.54E-05	9.60E-04
viral budding via host ESCRT complex (GO:0039702)	20	13	3.03	+	4.30	1.49E-04	2.75E-03
intra-Golgi vesicle-mediated transport (GO:0006891)	37	24	5.60	+	4.29	2.78E-07	9.70E-06
7-methylguanosine mRNA capping (GO:0006370)	34	22	5.14	+	4.28	8.92E-07	2.77E-05
drug metabolic process (GO:0017144)	48	31	7.26	+	4.27	5.74E-09	2.63E-07
phagosome acidification (GO:0090383)	28	18	4.24	+	4.25	9.27E-06	2.35E-04
COPII-coated vesicle cargo loading (GO:0090110)	14	9	2.12	+	4.25	1.66E-03	2.22E-02
maturation of SSU-rRNA (GO:0030490)	50	32	7.56	+	4.23	3.85E-09	1.87E-07
transcription elongation from RNA polymerase I promoter (GO:0006362)	30	19	4.54	+	4.19	6.16E-06	1.63E-04
nucleobase biosynthetic process (GO:0046112)	19	12	2.87	+	4.18	3.24E-04	5.45E-03
phosphatidylcholine biosynthetic process (GO:0006656)	35	22	5.29	+	4.16	1.27E-06	3.83E-05
RNA capping (GO:0036260)	35	22	5.29	+	4.16	1.27E-06	3.83E-05
7-methylguanosine RNA capping (GO:0009452)	35	22	5.29	+	4.16	1.27E-06	3.82E-05
anaphase-promoting complex-dependent catabolic process (GO:0031145)	86	54	13.01	+	4.15	3.46E-14	2.90E-12
nucleotide-sugar biosynthetic process (GO:0009226)	24	15	3.63	+	4.13	6.48E-05	1.32E-03
maturation of LSU-rRNA (GO:0000470)	29	18	4.39	+	4.10	1.32E-05	3.21E-04
purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	21	13	3.18	+	4.09	2.12E-04	3.74E-03
transcription-coupled nucleotide-excision repair (GO:0006283)	73	45	11.04	+	4.08	7.27E-12	4.73E-10
alditol metabolic process (GO:0019400)	26	16	3.93	+	4.07	4.27E-05	9.12E-04
cellular response to nitrogen starvation (GO:0006995)	13	8	1.97	+	4.07	3.65E-03	4.34E-02
IMP metabolic process (GO:0046040)	13	8	1.97	+	4.07	3.65E-03	4.33E-02
pentose-phosphate shunt (GO:0006098)	13	8	1.97	+	4.07	3.65E-03	4.33E-02
cellular response to nitrogen levels (GO:0043562)	13	8	1.97	+	4.07	3.65E-03	4.33E-02
nucleotide-sugar transmembrane transport (GO:0015780)	13	8	1.97	+	4.07	3.65E-03	4.32E-02
branched-chain amino acid metabolic process (GO:0009081)	26	16	3.93	+	4.07	4.27E-05	9.11E-04
cellular aldehyde metabolic process (GO:0006081)	57	35	8.62	+	4.06	1.63E-09	8.25E-08
NADP metabolic process (GO:0006739)	31	19	4.69	+	4.05	8.72E-06	2.22E-04
termination of RNA polymerase I transcription (GO:0006363)	31	19	4.69	+	4.05	8.72E-06	2.22E-04
regulation of cellular amino acid metabolic process (GO:0006521)	67	41	10.13	+	4.05	7.25E-11	4.29E-09
viral translation (GO:0019081)	18	11	2.72	+	4.04	7.01E-04	1.07E-02
protein localization to endoplasmic reticulum (GO:0070972)	144	88	21.78	+	4.04	1.22E-21	1.52E-19
glutamine family amino acid biosynthetic process (GO:0009084)	18	11	2.72	+	4.04	7.01E-04	1.07E-02
serine family amino acid biosynthetic process (GO:0009070)	18	11	2.72	+	4.04	7.01E-04	1.07E-02
metallo-sulfur cluster assembly (GO:0031163)	28	17	4.24	+	4.01	2.81E-05	6.28E-04
iron-sulfur cluster assembly (GO:0016226)	28	17	4.24	+	4.01	2.81E-05	6.27E-04
NADPH regeneration (GO:0006740)	15	9	2.27	+	3.97	2.35E-03	2.99E-02
protein heterotetramerization (GO:0051290)	15	9	2.27	+	3.97	2.35E-03	2.99E-02
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	15	9	2.27	+	3.97	2.35E-03	2.99E-02
multivesicular body assembly (GO:0036258)	30	18	4.54	+	3.97	1.85E-05	4.26E-04
regulation of protein localization to chromosome, telomeric region (GO:1904814)	15	9	2.27	+	3.97	2.35E-03	2.98E-02
phosphate ion transmembrane transport (GO:0035435)	15	9	2.27	+	3.97	2.35E-03	2.98E-02
protein maturation by iron-sulfur cluster transfer (GO:0097428)	15	9	2.27	+	3.97	2.35E-03	2.98E-02
purine ribonucleoside bisphosphate metabolic process (GO:0034035)	25	15	3.78	+	3.97	9.12E-05	1.78E-03
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	25	15	3.78	+	3.97	9.12E-05	1.78E-03
ribosomal large subunit biogenesis (GO:0042273)	75	45	11.34	+	3.97	1.43E-11	9.02E-10
'de novo' protein folding (GO:0006458)	42	25	6.35	+	3.94	5.22E-07	1.71E-05
mitotic interphase (GO:0051329)	79	47	11.95	+	3.93	6.32E-12	4.14E-10
interphase (GO:0051325)	79	47	11.95	+	3.93	6.32E-12	4.12E-10
DNA replication initiation (GO:0006270)	32	19	4.84	+	3.93	1.22E-05	3.00E-04
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	17	10	2.57	+	3.89	1.51E-03	2.06E-02
2-oxoglutarate metabolic process (GO:0006103)	17	10	2.57	+	3.89	1.51E-03	2.06E-02
acetyl-CoA biosynthetic process (GO:0006085)	17	10	2.57	+	3.89	1.51E-03	2.06E-02
primary alcohol metabolic process (GO:0034308)	85	50	12.86	+	3.89	1.85E-12	1.30E-10
viral transcription (GO:0019083)	116	68	17.55	+	3.88	2.31E-16	2.23E-14
nuclear-transcribed mRNA catabolic process (GO:0000956)	200	117	30.25	+	3.87	4.24E-27	7.64E-25
multivesicular body organization (GO:0036257)	31	18	4.69	+	3.84	2.57E-05	5.78E-04
regulation of translational elongation (GO:0006448)	19	11	2.87	+	3.83	9.77E-04	1.42E-02
negative regulation of RNA splicing (GO:0033119)	26	15	3.93	+	3.81	1.26E-04	2.37E-03
acetyl-CoA metabolic process (GO:0006084)	33	19	4.99	+	3.81	1.69E-05	3.95E-04
retinoic acid metabolic process (GO:0042573)	33	19	4.99	+	3.81	1.69E-05	3.95E-04
estrogen metabolic process (GO:0008210)	33	19	4.99	+	3.81	1.69E-05	3.94E-04
purine nucleoside bisphosphate biosynthetic process (GO:0034033)	63	36	9.53	+	3.78	4.00E-09	1.91E-07
ribonucleoside bisphosphate biosynthetic process (GO:0034030)	63	36	9.53	+	3.78	4.00E-09	1.90E-07
quinone metabolic process (GO:1901661)	35	20	5.29	+	3.78	1.11E-05	2.76E-04
organic cation transport (GO:0015695)	35	20	5.29	+	3.78	1.11E-05	2.76E-04
nucleoside bisphosphate biosynthetic process (GO:0033866)	63	36	9.53	+	3.78	4.00E-09	1.90E-07
carbohydrate derivative transport (GO:1901264)	93	53	14.07	+	3.77	1.02E-12	7.55E-11
nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)	37	21	5.60	+	3.75	7.26E-06	1.90E-04
glycerol metabolic process (GO:0006071)	23	13	3.48	+	3.74	4.10E-04	6.71E-03
purine nucleoside monophosphate biosynthetic process (GO:0009127)	23	13	3.48	+	3.74	4.10E-04	6.70E-03
aspartate family amino acid catabolic process (GO:0009068)	23	13	3.48	+	3.74	4.10E-04	6.69E-03
AMP metabolic process (GO:0046033)	16	9	2.42	+	3.72	3.24E-03	3.92E-02
acyl-CoA biosynthetic process (GO:0071616)	48	27	7.26	+	3.72	4.30E-07	1.44E-05
glycine metabolic process (GO:0006544)	16	9	2.42	+	3.72	3.24E-03	3.92E-02
UDP-N-acetylglucosamine metabolic process (GO:0006047)	16	9	2.42	+	3.72	3.24E-03	3.91E-02
chaperone cofactor-dependent protein refolding (GO:0051085)	32	18	4.84	+	3.72	3.53E-05	7.63E-04
thioester biosynthetic process (GO:0035384)	48	27	7.26	+	3.72	4.30E-07	1.43E-05
viral budding (GO:0046755)	25	14	3.78	+	3.70	2.66E-04	4.55E-03
protein targeting to membrane (GO:0006612)	184	103	27.83	+	3.70	6.35E-23	8.53E-21
mRNA catabolic process (GO:0006402)	220	123	33.28	+	3.70	4.34E-27	7.73E-25
maturation of 5.8S rRNA (GO:0000460)	36	20	5.45	+	3.67	1.51E-05	3.59E-04
'de novo' posttranslational protein folding (GO:0051084)	38	21	5.75	+	3.65	9.89E-06	2.49E-04
protein K11-linked ubiquitination (GO:0070979)	29	16	4.39	+	3.65	1.13E-04	2.13E-03
isoprenoid biosynthetic process (GO:0008299)	29	16	4.39	+	3.65	1.13E-04	2.12E-03
monocarboxylic acid catabolic process (GO:0072329)	122	67	18.45	+	3.63	4.23E-15	3.79E-13
fatty-acyl-CoA metabolic process (GO:0035337)	42	23	6.35	+	3.62	4.25E-06	1.16E-04
error-free translesion synthesis (GO:0070987)	22	12	3.33	+	3.61	8.61E-04	1.28E-02
negative regulation of mRNA splicing, via spliceosome (GO:0048025)	22	12	3.33	+	3.61	8.61E-04	1.28E-02
monosaccharide biosynthetic process (GO:0046364)	55	30	8.32	+	3.61	1.66E-07	5.97E-06
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	92	50	13.92	+	3.59	1.63E-11	1.02E-09
peroxisomal transport (GO:0043574)	81	44	12.25	+	3.59	2.66E-10	1.49E-08
ribonucleoside monophosphate biosynthetic process (GO:0009156)	35	19	5.29	+	3.59	3.12E-05	6.87E-04
fatty acid beta-oxidation (GO:0006635)	59	32	8.92	+	3.59	7.19E-08	2.72E-06
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	24	13	3.63	+	3.58	5.56E-04	8.77E-03
retinol metabolic process (GO:0042572)	48	26	7.26	+	3.58	1.20E-06	3.65E-05
DNA strand elongation (GO:0022616)	24	13	3.63	+	3.58	5.56E-04	8.76E-03
tRNA aminoacylation for protein translation (GO:0006418)	50	27	7.56	+	3.57	7.87E-07	2.49E-05
nucleotide-excision repair, DNA incision (GO:0033683)	39	21	5.90	+	3.56	1.33E-05	3.23E-04
transcription initiation from RNA polymerase I promoter (GO:0006361)	39	21	5.90	+	3.56	1.33E-05	3.23E-04
spliceosomal snRNP assembly (GO:0000387)	39	21	5.90	+	3.56	1.33E-05	3.22E-04
rRNA processing (GO:0006364)	260	140	39.33	+	3.56	2.04E-29	4.05E-27
viral gene expression (GO:0019080)	171	92	25.87	+	3.56	9.40E-20	1.04E-17
protein targeting to peroxisome (GO:0006625)	80	43	12.10	+	3.55	5.42E-10	2.93E-08
establishment of protein localization to peroxisome (GO:0072663)	80	43	12.10	+	3.55	5.42E-10	2.92E-08
protein localization to peroxisome (GO:0072662)	80	43	12.10	+	3.55	5.42E-10	2.91E-08
purine nucleoside bisphosphate metabolic process (GO:0034032)	135	72	20.42	+	3.53	1.28E-15	1.21E-13
ribonucleoside bisphosphate metabolic process (GO:0033875)	135	72	20.42	+	3.53	1.28E-15	1.20E-13
nucleoside bisphosphate metabolic process (GO:0033865)	135	72	20.42	+	3.53	1.28E-15	1.19E-13
fatty-acyl-CoA biosynthetic process (GO:0046949)	32	17	4.84	+	3.51	9.86E-05	1.91E-03
hexose biosynthetic process (GO:0019319)	49	26	7.41	+	3.51	1.61E-06	4.73E-05
mRNA cis splicing, via spliceosome (GO:0045292)	34	18	5.14	+	3.50	6.42E-05	1.31E-03
ribosomal small subunit biogenesis (GO:0042274)	74	39	11.19	+	3.48	5.14E-09	2.39E-07
tRNA wobble uridine modification (GO:0002098)	19	10	2.87	+	3.48	2.80E-03	3.45E-02
fatty acid transmembrane transport (GO:1902001)	19	10	2.87	+	3.48	2.80E-03	3.45E-02
response to oxygen radical (GO:0000305)	19	10	2.87	+	3.48	2.80E-03	3.45E-02
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)	19	10	2.87	+	3.48	2.80E-03	3.44E-02
acyl-CoA metabolic process (GO:0006637)	99	52	14.98	+	3.47	1.69E-11	1.05E-09
thioester metabolic process (GO:0035383)	99	52	14.98	+	3.47	1.69E-11	1.04E-09
fatty acid oxidation (GO:0019395)	84	44	12.71	+	3.46	6.36E-10	3.40E-08
error-prone translesion synthesis (GO:0042276)	21	11	3.18	+	3.46	1.80E-03	2.37E-02
nucleotide-excision repair (GO:0006289)	107	56	16.19	+	3.46	3.19E-12	2.16E-10
alpha-amino acid biosynthetic process (GO:1901607)	65	34	9.83	+	3.46	5.55E-08	2.12E-06
rRNA metabolic process (GO:0016072)	270	141	40.84	+	3.45	1.36E-28	2.66E-26
RNA catabolic process (GO:0006401)	251	131	37.97	+	3.45	1.25E-26	2.16E-24
nucleotide-excision repair, DNA gap filling (GO:0006297)	23	12	3.48	+	3.45	1.16E-03	1.62E-02
gluconeogenesis (GO:0006094)	46	24	6.96	+	3.45	4.99E-06	1.34E-04
intracellular pH reduction (GO:0051452)	48	25	7.26	+	3.44	3.27E-06	9.10E-05
ribonucleoprotein complex assembly (GO:0022618)	194	101	29.35	+	3.44	9.11E-21	1.06E-18
long-chain fatty-acyl-CoA metabolic process (GO:0035336)	25	13	3.78	+	3.44	7.45E-04	1.13E-02
folic acid-containing compound metabolic process (GO:0006760)	27	14	4.08	+	3.43	4.81E-04	7.73E-03
N-terminal protein amino acid modification (GO:0031365)	27	14	4.08	+	3.43	4.81E-04	7.72E-03
tRNA aminoacylation (GO:0043039)	54	28	8.17	+	3.43	9.19E-07	2.84E-05
ribonucleoprotein complex subunit organization (GO:0071826)	201	104	30.40	+	3.42	3.42E-21	4.11E-19
negative regulation of mRNA processing (GO:0050686)	31	16	4.69	+	3.41	2.02E-04	3.59E-03
monosaccharide catabolic process (GO:0046365)	62	32	9.38	+	3.41	1.71E-07	6.11E-06
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)	76	39	11.50	+	3.39	9.03E-09	4.00E-07
virion assembly (GO:0019068)	39	20	5.90	+	3.39	3.62E-05	7.84E-04
NIK/NF-kappaB signaling (GO:0038061)	80	41	12.10	+	3.39	3.91E-09	1.88E-07
transcription by RNA polymerase I (GO:0006360)	43	22	6.50	+	3.38	1.54E-05	3.66E-04
peroxisome organization (GO:0007031)	88	45	13.31	+	3.38	7.32E-10	3.87E-08
lipid oxidation (GO:0034440)	88	45	13.31	+	3.38	7.32E-10	3.86E-08
NAD metabolic process (GO:0019674)	45	23	6.81	+	3.38	1.01E-05	2.53E-04
dicarboxylic acid metabolic process (GO:0043648)	94	48	14.22	+	3.38	2.09E-10	1.19E-08
amino acid activation (GO:0043038)	55	28	8.32	+	3.37	1.21E-06	3.68E-05
cell cycle DNA replication (GO:0044786)	57	29	8.62	+	3.36	7.96E-07	2.51E-05
ribonucleoprotein complex biogenesis (GO:0022613)	468	238	70.79	+	3.36	2.86E-46	1.13E-43
chaperone-mediated protein folding (GO:0061077)	59	30	8.92	+	3.36	5.22E-07	1.71E-05
regulation of cellular amine metabolic process (GO:0033238)	87	44	13.16	+	3.34	1.46E-09	7.49E-08
triglyceride biosynthetic process (GO:0019432)	22	11	3.33	+	3.31	2.38E-03	3.01E-02
alcohol catabolic process (GO:0046164)	54	27	8.17	+	3.31	2.43E-06	6.94E-05
negative regulation of cell cycle G2/M phase transition (GO:1902750)	104	52	15.73	+	3.31	6.75E-11	4.01E-09
regulation of translational fidelity (GO:0006450)	26	13	3.93	+	3.31	9.84E-04	1.43E-02
protein exit from endoplasmic reticulum (GO:0032527)	24	12	3.63	+	3.31	1.53E-03	2.08E-02
protein peptidyl-prolyl isomerization (GO:0000413)	48	24	7.26	+	3.31	8.68E-06	2.22E-04
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)	78	39	11.80	+	3.31	1.56E-08	6.63E-07
phosphate ion transport (GO:0006817)	20	10	3.03	+	3.31	3.72E-03	4.40E-02
blastocyst growth (GO:0001832)	20	10	3.03	+	3.31	3.72E-03	4.40E-02
nuclear DNA replication (GO:0033260)	56	28	8.47	+	3.31	1.59E-06	4.72E-05
protein homotetramerization (GO:0051289)	56	28	8.47	+	3.31	1.59E-06	4.71E-05
regulation of mRNA 3'-end processing (GO:0031440)	28	14	4.24	+	3.31	6.36E-04	9.86E-03
glycolytic process through glucose-6-phosphate (GO:0061620)	28	14	4.24	+	3.31	6.36E-04	9.85E-03
glycolytic process through fructose-6-phosphate (GO:0061615)	28	14	4.24	+	3.31	6.36E-04	9.84E-03
fatty acid catabolic process (GO:0009062)	98	49	14.82	+	3.31	2.37E-10	1.33E-08
ribosome biogenesis (GO:0042254)	335	166	50.67	+	3.28	2.99E-31	6.67E-29
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)	81	40	12.25	+	3.26	1.34E-08	5.82E-07
regulation of hematopoietic stem cell differentiation (GO:1902036)	75	37	11.34	+	3.26	4.71E-08	1.84E-06
pyruvate metabolic process (GO:0006090)	71	35	10.74	+	3.26	1.09E-07	3.98E-06
translation (GO:0006412)	394	194	59.60	+	3.26	2.98E-36	8.29E-34
pH reduction (GO:0045851)	51	25	7.71	+	3.24	7.41E-06	1.94E-04
mitotic metaphase plate congression (GO:0007080)	45	22	6.81	+	3.23	2.65E-05	5.95E-04
one-carbon metabolic process (GO:0006730)	39	19	5.90	+	3.22	9.56E-05	1.85E-03
nucleotide-sugar metabolic process (GO:0009225)	39	19	5.90	+	3.22	9.56E-05	1.85E-03
endosome transport via multivesicular body sorting pathway (GO:0032509)	35	17	5.29	+	3.21	2.26E-04	3.93E-03
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)	101	49	15.28	+	3.21	5.22E-10	2.85E-08
aspartate family amino acid metabolic process (GO:0009066)	58	28	8.77	+	3.19	2.70E-06	7.63E-05
NADH regeneration (GO:0006735)	27	13	4.08	+	3.18	1.28E-03	1.79E-02
nucleobase-containing small molecule interconversion (GO:0015949)	27	13	4.08	+	3.18	1.28E-03	1.79E-02
glucose catabolic process to pyruvate (GO:0061718)	27	13	4.08	+	3.18	1.28E-03	1.79E-02
canonical glycolysis (GO:0061621)	27	13	4.08	+	3.18	1.28E-03	1.79E-02
transcription elongation from RNA polymerase II promoter (GO:0006368)	75	36	11.34	+	3.17	1.21E-07	4.37E-06
regulation of spindle assembly (GO:0090169)	25	12	3.78	+	3.17	1.99E-03	2.60E-02
glutamine family amino acid metabolic process (GO:0009064)	73	35	11.04	+	3.17	1.83E-07	6.54E-06
nucleoside monophosphate biosynthetic process (GO:0009124)	46	22	6.96	+	3.16	3.44E-05	7.50E-04
sterol biosynthetic process (GO:0016126)	46	22	6.96	+	3.16	3.44E-05	7.49E-04
peptide biosynthetic process (GO:0043043)	419	200	63.38	+	3.16	6.24E-36	1.65E-33
RNA splicing, via transesterification reactions (GO:0000375)	307	146	46.44	+	3.14	2.98E-26	4.98E-24
cellular ketone metabolic process (GO:0042180)	80	38	12.10	+	3.14	6.72E-08	2.55E-06
NADH metabolic process (GO:0006734)	38	18	5.75	+	3.13	1.90E-04	3.38E-03
mRNA splicing, via spliceosome (GO:0000398)	304	144	45.98	+	3.13	8.27E-26	1.30E-23
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	304	144	45.98	+	3.13	8.27E-26	1.29E-23
transferrin transport (GO:0033572)	36	17	5.45	+	3.12	2.92E-04	4.96E-03
nucleobase metabolic process (GO:0009112)	36	17	5.45	+	3.12	2.92E-04	4.96E-03
xenobiotic transport (GO:0042908)	34	16	5.14	+	3.11	4.50E-04	7.25E-03
ribosome assembly (GO:0042255)	68	32	10.29	+	3.11	8.32E-07	2.62E-05
cellular amino acid biosynthetic process (GO:0008652)	83	39	12.55	+	3.11	8.96E-08	3.30E-06
interleukin-1-mediated signaling pathway (GO:0070498)	96	45	14.52	+	3.10	8.16E-09	3.67E-07
DNA-templated transcription, elongation (GO:0006354)	92	43	13.92	+	3.09	1.89E-08	7.91E-07
glutamate metabolic process (GO:0006536)	30	14	4.54	+	3.09	1.07E-03	1.53E-02
protein N-linked glycosylation (GO:0006487)	75	35	11.34	+	3.09	4.83E-07	1.60E-05
spliceosomal complex assembly (GO:0000245)	56	26	8.47	+	3.07	1.04E-05	2.61E-04
tRNA methylation (GO:0030488)	41	19	6.20	+	3.06	1.59E-04	2.89E-03
hexose catabolic process (GO:0019320)	52	24	7.87	+	3.05	2.42E-05	5.46E-04
cellular carbohydrate catabolic process (GO:0044275)	39	18	5.90	+	3.05	2.44E-04	4.22E-03
DNA damage response, detection of DNA damage (GO:0042769)	39	18	5.90	+	3.05	2.44E-04	4.22E-03
carbohydrate phosphorylation (GO:0046835)	26	12	3.93	+	3.05	2.57E-03	3.20E-02
organic hydroxy compound catabolic process (GO:1901616)	76	35	11.50	+	3.04	5.43E-07	1.77E-05
protein targeting (GO:0006605)	374	172	56.57	+	3.04	1.54E-29	3.14E-27
ncRNA processing (GO:0034470)	433	199	65.50	+	3.04	5.88E-34	1.43E-31
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	61	28	9.23	+	3.03	9.23E-06	2.34E-04
vesicle-mediated transport between endosomal compartments (GO:0098927)	24	11	3.63	+	3.03	4.00E-03	4.63E-02
protein alpha-1,2-demannosylation (GO:0036508)	24	11	3.63	+	3.03	4.00E-03	4.63E-02
protein demannosylation (GO:0036507)	24	11	3.63	+	3.03	4.00E-03	4.63E-02
protein heterooligomerization (GO:0051291)	24	11	3.63	+	3.03	4.00E-03	4.62E-02
histone mRNA metabolic process (GO:0008334)	24	11	3.63	+	3.03	4.00E-03	4.62E-02
secondary metabolic process (GO:0019748)	48	22	7.26	+	3.03	5.66E-05	1.17E-03
amide biosynthetic process (GO:0043604)	548	250	82.89	+	3.02	3.28E-42	1.13E-39
M phase (GO:0000279)	171	78	25.87	+	3.02	7.61E-14	6.13E-12
mitotic M phase (GO:0000087)	171	78	25.87	+	3.02	7.61E-14	6.09E-12
DNA-templated transcription, termination (GO:0006353)	79	36	11.95	+	3.01	4.13E-07	1.39E-05
regulation of cholesterol biosynthetic process (GO:0045540)	44	20	6.66	+	3.00	1.32E-04	2.47E-03
pyrimidine nucleotide biosynthetic process (GO:0006221)	33	15	4.99	+	3.00	8.88E-04	1.31E-02
regulation of hematopoietic progenitor cell differentiation (GO:1901532)	88	40	13.31	+	3.00	9.17E-08	3.36E-06
regulation of sterol biosynthetic process (GO:0106118)	44	20	6.66	+	3.00	1.32E-04	2.47E-03
olefinic compound metabolic process (GO:0120254)	110	50	16.64	+	3.00	2.10E-09	1.06E-07
positive regulation of mRNA processing (GO:0050685)	33	15	4.99	+	3.00	8.88E-04	1.31E-02
protein folding (GO:0006457)	229	104	34.64	+	3.00	4.90E-18	5.04E-16
establishment of protein localization to membrane (GO:0090150)	293	133	44.32	+	3.00	1.16E-22	1.55E-20
mitochondrial transmembrane transport (GO:1990542)	106	48	16.03	+	2.99	4.84E-09	2.26E-07
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	95	43	14.37	+	2.99	3.17E-08	1.28E-06
fat-soluble vitamin metabolic process (GO:0006775)	42	19	6.35	+	2.99	2.03E-04	3.59E-03
anaphase (GO:0051322)	157	71	23.75	+	2.99	1.39E-12	9.90E-11
mitotic anaphase (GO:0000090)	157	71	23.75	+	2.99	1.39E-12	9.85E-11
glucose catabolic process (GO:0006007)	31	14	4.69	+	2.99	1.37E-03	1.89E-02
cellular amino acid catabolic process (GO:0009063)	124	56	18.76	+	2.99	2.69E-10	1.49E-08
reactive oxygen species biosynthetic process (GO:1903409)	31	14	4.69	+	2.99	1.37E-03	1.89E-02
phosphatidylethanolamine metabolic process (GO:0046337)	31	14	4.69	+	2.99	1.37E-03	1.89E-02
arachidonic acid metabolic process (GO:0019369)	60	27	9.08	+	2.97	1.57E-05	3.71E-04
secondary alcohol biosynthetic process (GO:1902653)	40	18	6.05	+	2.97	3.11E-04	5.24E-03
cholesterol biosynthetic process (GO:0006695)	40	18	6.05	+	2.97	3.11E-04	5.23E-03
carbohydrate transport (GO:0008643)	80	36	12.10	+	2.97	4.88E-07	1.61E-05
organic acid catabolic process (GO:0016054)	267	120	40.39	+	2.97	2.69E-20	3.02E-18
carboxylic acid catabolic process (GO:0046395)	267	120	40.39	+	2.97	2.69E-20	3.00E-18
aerobic respiration (GO:0009060)	78	35	11.80	+	2.97	7.42E-07	2.36E-05
acylglycerol biosynthetic process (GO:0046463)	29	13	4.39	+	2.96	2.12E-03	2.74E-02
neutral lipid biosynthetic process (GO:0046460)	29	13	4.39	+	2.96	2.12E-03	2.74E-02
carbohydrate catabolic process (GO:0016052)	121	54	18.30	+	2.95	1.25E-09	6.43E-08
tRNA modification (GO:0006400)	92	41	13.92	+	2.95	8.90E-08	3.28E-06
regulation of protein exit from endoplasmic reticulum (GO:0070861)	27	12	4.08	+	2.94	3.28E-03	3.94E-02
vesicle docking (GO:0048278)	63	28	9.53	+	2.94	1.18E-05	2.93E-04
vesicle cargo loading (GO:0035459)	27	12	4.08	+	2.94	3.28E-03	3.94E-02
cytokinetic process (GO:0032506)	36	16	5.45	+	2.94	7.32E-04	1.11E-02
phagosome maturation (GO:0090382)	45	20	6.81	+	2.94	2.72E-04	4.64E-03
ribose phosphate biosynthetic process (GO:0046390)	178	79	26.92	+	2.93	1.28E-13	9.99E-12
mitotic sister chromatid segregation (GO:0000070)	111	49	16.79	+	2.92	9.78E-09	4.30E-07
cellular hormone metabolic process (GO:0034754)	127	56	19.21	+	2.92	6.88E-10	3.66E-08
cellular amino acid metabolic process (GO:0006520)	295	130	44.62	+	2.91	2.67E-21	3.26E-19
protein deglycosylation (GO:0006517)	32	14	4.84	+	2.89	1.73E-03	2.30E-02
metaphase plate congression (GO:0051310)	55	24	8.32	+	2.88	6.36E-05	1.30E-03
ncRNA metabolic process (GO:0034660)	525	229	79.41	+	2.88	3.16E-36	8.64E-34
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	85	37	12.86	+	2.88	5.75E-07	1.87E-05
unsaturated fatty acid metabolic process (GO:0033559)	108	47	16.34	+	2.88	2.46E-08	1.01E-06
xenobiotic metabolic process (GO:0006805)	122	53	18.45	+	2.87	2.75E-09	1.37E-07
small molecule catabolic process (GO:0044282)	434	188	65.65	+	2.86	1.47E-29	3.03E-27
cellular response to xenobiotic stimulus (GO:0071466)	127	55	19.21	+	2.86	1.43E-09	7.34E-08
ribonucleotide biosynthetic process (GO:0009260)	171	74	25.87	+	2.86	2.53E-12	1.74E-10
mRNA metabolic process (GO:0016071)	700	302	105.88	+	2.85	3.81E-47	1.55E-44
peptide metabolic process (GO:0006518)	538	232	81.38	+	2.85	4.54E-36	1.22E-33
nucleobase-containing compound catabolic process (GO:0034655)	383	165	57.93	+	2.85	6.53E-26	1.06E-23
glycolytic process (GO:0006096)	42	18	6.35	+	2.83	7.04E-04	1.08E-02
COPII-coated vesicle budding (GO:0090114)	70	30	10.59	+	2.83	8.63E-06	2.21E-04
very long-chain fatty acid metabolic process (GO:0000038)	35	15	5.29	+	2.83	2.28E-03	2.92E-02
sulfur compound transport (GO:0072348)	49	21	7.41	+	2.83	2.25E-04	3.92E-03
protein targeting to mitochondrion (GO:0006626)	56	24	8.47	+	2.83	7.41E-05	1.47E-03
purine ribonucleotide biosynthetic process (GO:0009152)	157	67	23.75	+	2.82	4.42E-11	2.63E-09
fatty acid derivative metabolic process (GO:1901568)	169	72	25.56	+	2.82	7.79E-12	5.05E-10
alpha-amino acid metabolic process (GO:1901605)	207	88	31.31	+	2.81	4.62E-14	3.84E-12
serine family amino acid metabolic process (GO:0009069)	40	17	6.05	+	2.81	1.08E-03	1.54E-02
sister chromatid segregation (GO:0000819)	139	59	21.03	+	2.81	9.09E-10	4.75E-08
DNA duplex unwinding (GO:0032508)	111	47	16.79	+	2.80	3.81E-08	1.52E-06
ribonucleoside monophosphate metabolic process (GO:0009161)	52	22	7.87	+	2.80	1.72E-04	3.08E-03
mRNA 3'-end processing (GO:0031124)	90	38	13.61	+	2.79	9.83E-07	3.03E-05
L-amino acid transport (GO:0015807)	64	27	9.68	+	2.79	3.00E-05	6.66E-04
telomere maintenance via semi-conservative replication (GO:0032201)	38	16	5.75	+	2.78	1.65E-03	2.21E-02
sulfur amino acid metabolic process (GO:0000096)	38	16	5.75	+	2.78	1.65E-03	2.20E-02
purine ribonucleoside monophosphate metabolic process (GO:0009167)	38	16	5.75	+	2.78	1.65E-03	2.20E-02
purine nucleotide biosynthetic process (GO:0006164)	167	70	25.26	+	2.77	2.53E-11	1.54E-09
ATP generation from ADP (GO:0006757)	43	18	6.50	+	2.77	7.98E-04	1.20E-02
protein tetramerization (GO:0051262)	86	36	13.01	+	2.77	2.22E-06	6.41E-05
pyrimidine-containing compound biosynthetic process (GO:0072528)	43	18	6.50	+	2.77	7.98E-04	1.20E-02
tRNA metabolic process (GO:0006399)	196	82	29.65	+	2.77	6.13E-13	4.59E-11
vesicle coating (GO:0006901)	67	28	10.13	+	2.76	2.40E-05	5.42E-04
response to xenobiotic stimulus (GO:0009410)	134	56	20.27	+	2.76	3.40E-09	1.66E-07
positive regulation of gene expression, epigenetic (GO:0045815)	60	25	9.08	+	2.75	6.90E-05	1.38E-03
protein transmembrane import into intracellular organelle (GO:0044743)	36	15	5.45	+	2.75	2.52E-03	3.16E-02
RNA processing (GO:0006396)	929	387	140.52	+	2.75	9.35E-58	5.30E-55
DNA geometric change (GO:0032392)	118	49	17.85	+	2.75	4.72E-08	1.83E-06
multivesicular body sorting pathway (GO:0071985)	41	17	6.20	+	2.74	1.22E-03	1.70E-02
vitamin transport (GO:0051180)	41	17	6.20	+	2.74	1.22E-03	1.70E-02
RNA splicing (GO:0008380)	410	170	62.02	+	2.74	4.30E-25	6.37E-23
cellular amide metabolic process (GO:0043603)	816	338	123.43	+	2.74	1.06E-49	4.81E-47
interleukin-12-mediated signaling pathway (GO:0035722)	46	19	6.96	+	2.73	6.05E-04	9.42E-03
COPII vesicle coating (GO:0048208)	63	26	9.53	+	2.73	5.49E-05	1.15E-03
vesicle targeting, rough ER to cis-Golgi (GO:0048207)	63	26	9.53	+	2.73	5.49E-05	1.14E-03
isoprenoid metabolic process (GO:0006720)	143	59	21.63	+	2.73	1.55E-09	7.88E-08
Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	97	40	14.67	+	2.73	6.66E-07	2.14E-05
vesicle budding from membrane (GO:0006900)	102	42	15.43	+	2.72	3.50E-07	1.19E-05
ADP metabolic process (GO:0046031)	51	21	7.71	+	2.72	3.07E-04	5.18E-03
Golgi vesicle budding (GO:0048194)	78	32	11.80	+	2.71	1.14E-05	2.82E-04
pteridine-containing compound metabolic process (GO:0042558)	39	16	5.90	+	2.71	1.86E-03	2.44E-02
purine-containing compound biosynthetic process (GO:0072522)	178	73	26.92	+	2.71	2.34E-11	1.44E-09
establishment of protein localization to organelle (GO:0072594)	454	186	68.67	+	2.71	5.41E-27	9.53E-25
alpha-amino acid catabolic process (GO:1901606)	105	43	15.88	+	2.71	2.79E-07	9.70E-06
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	198	81	29.95	+	2.70	2.76E-12	1.89E-10
peptidyl-proline modification (GO:0018208)	66	27	9.98	+	2.70	4.39E-05	9.32E-04
ribose phosphate metabolic process (GO:0019693)	343	140	51.88	+	2.70	2.04E-20	2.32E-18
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	59	24	8.92	+	2.69	1.26E-04	2.35E-03
monocarboxylic acid metabolic process (GO:0032787)	542	220	81.98	+	2.68	2.82E-31	6.39E-29
carboxylic acid transmembrane transport (GO:1905039)	143	58	21.63	+	2.68	3.29E-09	1.62E-07
positive regulation of RNA splicing (GO:0033120)	37	15	5.60	+	2.68	2.84E-03	3.48E-02
mRNA polyadenylation (GO:0006378)	37	15	5.60	+	2.68	2.84E-03	3.48E-02
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	111	45	16.79	+	2.68	2.55E-07	8.92E-06
positive regulation of telomere maintenance via telomere lengthening (GO:1904358)	37	15	5.60	+	2.68	2.84E-03	3.48E-02
carboxylic acid metabolic process (GO:0019752)	904	366	136.74	+	2.68	4.00E-52	1.98E-49
carbohydrate transmembrane transport (GO:0034219)	42	17	6.35	+	2.68	1.40E-03	1.93E-02
organophosphate ester transport (GO:0015748)	141	57	21.33	+	2.67	4.93E-09	2.30E-07
intracellular protein transmembrane transport (GO:0065002)	52	21	7.87	+	2.67	3.64E-04	6.03E-03
postreplication repair (GO:0006301)	52	21	7.87	+	2.67	3.64E-04	6.03E-03
cellular nitrogen compound catabolic process (GO:0044270)	441	178	66.71	+	2.67	3.27E-25	4.94E-23
regulation of mitotic metaphase/anaphase transition (GO:0030071)	57	23	8.62	+	2.67	1.90E-04	3.38E-03
vitamin metabolic process (GO:0006766)	124	50	18.76	+	2.67	5.01E-08	1.93E-06
organic acid transmembrane transport (GO:1903825)	144	58	21.78	+	2.66	5.82E-09	2.65E-07
nucleotide biosynthetic process (GO:0009165)	236	95	35.70	+	2.66	5.89E-14	4.79E-12
ribonucleotide metabolic process (GO:0009259)	333	134	50.37	+	2.66	3.21E-19	3.46E-17
purine ribonucleotide metabolic process (GO:0009150)	316	127	47.80	+	2.66	3.37E-18	3.50E-16
fatty acid metabolic process (GO:0006631)	332	133	50.22	+	2.65	8.71E-19	9.28E-17
glucose metabolic process (GO:0006006)	115	46	17.40	+	2.64	2.16E-07	7.64E-06
nucleoside phosphate biosynthetic process (GO:1901293)	240	96	36.30	+	2.64	5.31E-14	4.38E-12
vesicle targeting, to, from or within Golgi (GO:0048199)	70	28	10.59	+	2.64	5.75E-05	1.19E-03
vesicle fusion (GO:0006906)	80	32	12.10	+	2.64	1.47E-05	3.51E-04
cell redox homeostasis (GO:0045454)	45	18	6.81	+	2.64	1.07E-03	1.53E-02
monosaccharide transmembrane transport (GO:0015749)	40	16	6.05	+	2.64	2.13E-03	2.75E-02
heterocycle catabolic process (GO:0046700)	440	176	66.56	+	2.64	1.16E-24	1.67E-22
organophosphate biosynthetic process (GO:0090407)	536	214	81.08	+	2.64	1.17E-29	2.45E-27
protein-DNA complex assembly (GO:0065004)	203	81	30.71	+	2.64	5.38E-12	3.60E-10
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	178	71	26.92	+	2.64	1.46E-10	8.48E-09
alcohol metabolic process (GO:0006066)	330	131	49.92	+	2.62	2.35E-18	2.47E-16
autophagosome assembly (GO:0000045)	63	25	9.53	+	2.62	1.75E-04	3.13E-03
regulation of mRNA processing (GO:0050684)	154	61	23.29	+	2.62	2.89E-09	1.43E-07
purine nucleotide metabolic process (GO:0006163)	341	135	51.58	+	2.62	7.28E-19	7.80E-17
cellular response to interleukin-12 (GO:0071349)	48	19	7.26	+	2.62	8.35E-04	1.25E-02
vesicle targeting (GO:0006903)	91	36	13.76	+	2.62	4.76E-06	1.28E-04
tRNA processing (GO:0008033)	134	53	20.27	+	2.61	4.19E-08	1.65E-06
toxin transport (GO:1901998)	43	17	6.50	+	2.61	1.63E-03	2.21E-02
organelle membrane fusion (GO:0090174)	86	34	13.01	+	2.61	8.99E-06	2.29E-04
terpenoid metabolic process (GO:0006721)	124	49	18.76	+	2.61	1.03E-07	3.77E-06
icosanoid metabolic process (GO:0006690)	114	45	17.24	+	2.61	3.72E-07	1.26E-05
RNA polyadenylation (GO:0043631)	38	15	5.75	+	2.61	3.25E-03	3.91E-02
phospholipid biosynthetic process (GO:0008654)	256	101	38.72	+	2.61	2.44E-14	2.07E-12
mitotic nuclear division (GO:0140014)	170	67	25.71	+	2.61	7.06E-10	3.74E-08
nucleoside diphosphate phosphorylation (GO:0006165)	61	24	9.23	+	2.60	2.62E-04	4.49E-03
organic cyclic compound catabolic process (GO:1901361)	490	192	74.12	+	2.59	6.78E-26	1.09E-23
aromatic compound catabolic process (GO:0019439)	457	179	69.13	+	2.59	3.34E-24	4.65E-22
organelle fusion (GO:0048284)	105	41	15.88	+	2.58	1.59E-06	4.72E-05
organic acid metabolic process (GO:0006082)	1017	397	153.84	+	2.58	1.68E-53	8.59E-51
purine nucleoside monophosphate metabolic process (GO:0009126)	41	16	6.20	+	2.58	2.48E-03	3.12E-02
regulation of cholesterol metabolic process (GO:0090181)	59	23	8.92	+	2.58	3.92E-04	6.45E-03
oxoacid metabolic process (GO:0043436)	996	388	150.66	+	2.58	4.99E-52	2.40E-49
L-alpha-amino acid transmembrane transport (GO:1902475)	54	21	8.17	+	2.57	8.08E-04	1.21E-02
biological phase (GO:0044848)	270	105	40.84	+	2.57	1.65E-14	1.43E-12
mitotic cell cycle phase (GO:0098763)	270	105	40.84	+	2.57	1.65E-14	1.42E-12
cell cycle phase (GO:0022403)	270	105	40.84	+	2.57	1.65E-14	1.41E-12
purine-containing compound metabolic process (GO:0072521)	376	146	56.88	+	2.57	1.12E-19	1.24E-17
response to interleukin-12 (GO:0070671)	49	19	7.41	+	2.56	9.91E-04	1.43E-02
organelle disassembly (GO:1903008)	75	29	11.34	+	2.56	5.76E-05	1.19E-03
RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	44	17	6.66	+	2.55	1.92E-03	2.51E-02
regulation of intracellular pH (GO:0051453)	88	34	13.31	+	2.55	1.83E-05	4.23E-04
chromosome condensation (GO:0030261)	44	17	6.66	+	2.55	1.92E-03	2.51E-02
protein-DNA complex subunit organization (GO:0071824)	246	95	37.21	+	2.55	5.53E-13	4.16E-11
regulation of cell cycle G2/M phase transition (GO:1902749)	215	83	32.52	+	2.55	1.65E-11	1.02E-09
nucleobase-containing compound transport (GO:0015931)	267	103	40.39	+	2.55	4.17E-14	3.48E-12
nucleoside phosphate metabolic process (GO:0006753)	447	172	67.61	+	2.54	1.40E-22	1.85E-20
membrane protein proteolysis (GO:0033619)	39	15	5.90	+	2.54	3.76E-03	4.44E-02
viral protein processing (GO:0019082)	39	15	5.90	+	2.54	3.76E-03	4.44E-02
intracellular lipid transport (GO:0032365)	39	15	5.90	+	2.54	3.76E-03	4.43E-02
regulation of DNA-templated transcription in response to stress (GO:0043620)	117	45	17.70	+	2.54	8.82E-07	2.75E-05
alcohol biosynthetic process (GO:0046165)	99	38	14.98	+	2.54	5.24E-06	1.41E-04
antigen processing and presentation of exogenous antigen (GO:0019884)	185	71	27.98	+	2.54	5.38E-10	2.92E-08
mRNA processing (GO:0006397)	489	187	73.97	+	2.53	2.50E-24	3.51E-22
regulation of chromosome separation (GO:1905818)	68	26	10.29	+	2.53	1.66E-04	3.00E-03
nucleoside triphosphate biosynthetic process (GO:0009142)	68	26	10.29	+	2.53	1.66E-04	3.00E-03
nucleotide metabolic process (GO:0009117)	435	166	65.80	+	2.52	1.49E-21	1.83E-19
antigen processing and presentation of peptide antigen (GO:0048002)	194	74	29.35	+	2.52	2.42E-10	1.35E-08
oxidation-reduction process (GO:0055114)	970	370	146.73	+	2.52	8.19E-48	3.51E-45
nucleobase-containing small molecule metabolic process (GO:0055086)	527	201	79.72	+	2.52	7.09E-26	1.12E-23
amino sugar metabolic process (GO:0006040)	42	16	6.35	+	2.52	2.90E-03	3.54E-02
nucleotide phosphorylation (GO:0046939)	63	24	9.53	+	2.52	3.25E-04	5.47E-03
ribonucleoside triphosphate metabolic process (GO:0009199)	71	27	10.74	+	2.51	1.29E-04	2.40E-03
nucleosome assembly (GO:0006334)	116	44	17.55	+	2.51	1.42E-06	4.23E-05
nucleoside diphosphate metabolic process (GO:0009132)	87	33	13.16	+	2.51	2.97E-05	6.60E-04
fatty acid biosynthetic process (GO:0006633)	132	50	19.97	+	2.50	2.25E-07	7.94E-06
autophagosome organization (GO:1905037)	66	25	9.98	+	2.50	2.48E-04	4.28E-03
establishment of chromosome localization (GO:0051303)	74	28	11.19	+	2.50	1.00E-04	1.93E-03
chromosome localization (GO:0050000)	74	28	11.19	+	2.50	1.00E-04	1.93E-03
small molecule biosynthetic process (GO:0044283)	590	223	89.25	+	2.50	2.63E-28	5.02E-26
hexose metabolic process (GO:0019318)	159	60	24.05	+	2.49	1.61E-08	6.81E-07
protein transmembrane transport (GO:0071806)	61	23	9.23	+	2.49	4.86E-04	7.79E-03
protein lipidation (GO:0006497)	85	32	12.86	+	2.49	4.40E-05	9.32E-04
monosaccharide metabolic process (GO:0005996)	202	76	30.56	+	2.49	2.68E-10	1.49E-08
glycerolipid biosynthetic process (GO:0045017)	240	90	36.30	+	2.48	5.88E-12	3.89E-10
ribonucleoside triphosphate biosynthetic process (GO:0009201)	56	21	8.47	+	2.48	9.65E-04	1.40E-02
regulation of mRNA splicing, via spliceosome (GO:0048024)	115	43	17.40	+	2.47	2.33E-06	6.68E-05
water-soluble vitamin metabolic process (GO:0006767)	83	31	12.55	+	2.47	6.51E-05	1.32E-03
mitochondrial transport (GO:0006839)	233	87	35.24	+	2.47	1.65E-11	1.03E-09
glycerophospholipid biosynthetic process (GO:0046474)	220	82	33.28	+	2.46	8.09E-11	4.77E-09
purine nucleoside triphosphate biosynthetic process (GO:0009145)	51	19	7.71	+	2.46	1.95E-03	2.55E-02
autophagy of mitochondrion (GO:0000422)	43	16	6.50	+	2.46	3.41E-03	4.08E-02
mitochondrion disassembly (GO:0061726)	43	16	6.50	+	2.46	3.41E-03	4.08E-02
regulation of mitotic sister chromatid separation (GO:0010965)	62	23	9.38	+	2.45	5.53E-04	8.73E-03
long-chain fatty acid metabolic process (GO:0001676)	116	43	17.55	+	2.45	2.63E-06	7.43E-05
chromatin silencing (GO:0006342)	54	20	8.17	+	2.45	1.44E-03	1.97E-02
steroid biosynthetic process (GO:0006694)	127	47	19.21	+	2.45	1.26E-06	3.80E-05
nucleoside monophosphate metabolic process (GO:0009123)	73	27	11.04	+	2.45	2.60E-04	4.47E-03
lipid biosynthetic process (GO:0008610)	603	223	91.21	+	2.44	3.93E-27	7.17E-25
substantia nigra development (GO:0021762)	46	17	6.96	+	2.44	3.99E-03	4.63E-02
regulation of mRNA metabolic process (GO:1903311)	352	130	53.24	+	2.44	3.43E-16	3.30E-14
purine ribonucleoside triphosphate metabolic process (GO:0009205)	65	24	9.83	+	2.44	4.26E-04	6.92E-03
regulation of chromosome segregation (GO:0051983)	84	31	12.71	+	2.44	7.26E-05	1.44E-03
regulation of pH (GO:0006885)	103	38	15.58	+	2.44	1.31E-05	3.20E-04
regulation of cellular pH (GO:0030641)	95	35	14.37	+	2.44	2.27E-05	5.15E-04
diterpenoid metabolic process (GO:0016101)	114	42	17.24	+	2.44	3.87E-06	1.06E-04
sulfur compound metabolic process (GO:0006790)	375	138	56.72	+	2.43	5.14E-17	5.16E-15
positive regulation of DNA biosynthetic process (GO:2000573)	68	25	10.29	+	2.43	3.32E-04	5.57E-03
regulation of sister chromatid segregation (GO:0033045)	68	25	10.29	+	2.43	3.32E-04	5.56E-03
pyrimidine nucleotide metabolic process (GO:0006220)	49	18	7.41	+	2.43	2.90E-03	3.55E-02
mitotic spindle assembly (GO:0090307)	49	18	7.41	+	2.43	2.90E-03	3.54E-02
lipoprotein biosynthetic process (GO:0042158)	90	33	13.61	+	2.42	4.30E-05	9.15E-04
RNA 3'-end processing (GO:0031123)	142	52	21.48	+	2.42	3.12E-07	1.08E-05
organic hydroxy compound metabolic process (GO:1901615)	481	176	72.76	+	2.42	3.02E-21	3.66E-19
DNA conformation change (GO:0071103)	309	113	46.74	+	2.42	5.84E-14	4.77E-12
telomere organization (GO:0032200)	104	38	15.73	+	2.42	1.44E-05	3.43E-04
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	329	120	49.77	+	2.41	1.19E-14	1.03E-12
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	198	72	29.95	+	2.40	3.01E-09	1.48E-07
small molecule metabolic process (GO:0044281)	1748	635	264.41	+	2.40	2.84E-78	2.65E-75
nucleosome organization (GO:0034728)	157	57	23.75	+	2.40	1.17E-07	4.26E-06
stimulatory C-type lectin receptor signaling pathway (GO:0002223)	113	41	17.09	+	2.40	6.50E-06	1.71E-04
cellular respiration (GO:0045333)	160	58	24.20	+	2.40	9.03E-08	3.32E-06
spindle assembly (GO:0051225)	94	34	14.22	+	2.39	5.58E-05	1.16E-03
retinoid metabolic process (GO:0001523)	108	39	16.34	+	2.39	1.23E-05	3.03E-04
purine nucleoside triphosphate metabolic process (GO:0009144)	72	26	10.89	+	2.39	4.13E-04	6.74E-03
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	50	18	7.56	+	2.38	3.19E-03	3.87E-02
regulation of centrosome cycle (GO:0046605)	50	18	7.56	+	2.38	3.19E-03	3.87E-02
organonitrogen compound biosynthetic process (GO:1901566)	1403	505	212.22	+	2.38	8.85E-60	5.40E-57
carboxylic acid biosynthetic process (GO:0046394)	314	113	47.50	+	2.38	1.52E-13	1.17E-11
proteasomal protein catabolic process (GO:0010498)	351	126	53.09	+	2.37	4.93E-15	4.39E-13
organic acid biosynthetic process (GO:0016053)	315	113	47.65	+	2.37	1.62E-13	1.25E-11
regulation of microtubule polymerization (GO:0031113)	53	19	8.02	+	2.37	2.39E-03	3.03E-02
fatty acid derivative biosynthetic process (GO:1901570)	95	34	14.37	+	2.37	6.04E-05	1.24E-03
nucleoside triphosphate metabolic process (GO:0009141)	95	34	14.37	+	2.37	6.04E-05	1.24E-03
intracellular protein transport (GO:0006886)	992	355	150.05	+	2.37	5.96E-41	1.93E-38
organophosphate metabolic process (GO:0019637)	903	323	136.59	+	2.36	4.13E-37	1.19E-34
positive regulation of ATPase activity (GO:0032781)	56	20	8.47	+	2.36	1.82E-03	2.40E-02
regulation of stem cell differentiation (GO:2000736)	115	41	17.40	+	2.36	1.20E-05	2.97E-04
telomere maintenance (GO:0000723)	101	36	15.28	+	2.36	3.45E-05	7.49E-04
generation of precursor metabolites and energy (GO:0006091)	413	147	62.47	+	2.35	4.51E-17	4.58E-15
antigen processing and presentation (GO:0019882)	222	79	33.58	+	2.35	8.81E-10	4.61E-08
non-canonical Wnt signaling pathway (GO:0035567)	135	48	20.42	+	2.35	2.43E-06	6.93E-05
chromatin organization involved in negative regulation of transcription (GO:0097549)	76	27	11.50	+	2.35	3.43E-04	5.72E-03
proton transmembrane transport (GO:1902600)	138	49	20.87	+	2.35	1.79E-06	5.26E-05
regulation of RNA stability (GO:0043487)	203	72	30.71	+	2.34	7.71E-09	3.48E-07
cellular macromolecule catabolic process (GO:0044265)	926	328	140.07	+	2.34	4.90E-37	1.39E-34
innate immune response activating cell surface receptor signaling pathway (GO:0002220)	116	41	17.55	+	2.34	1.30E-05	3.19E-04
polyol metabolic process (GO:0019751)	122	43	18.45	+	2.33	7.53E-06	1.97E-04
pyrimidine-containing compound metabolic process (GO:0072527)	88	31	13.31	+	2.33	1.73E-04	3.10E-03
endosome organization (GO:0007032)	77	27	11.65	+	2.32	3.87E-04	6.37E-03
innate immune response-activating signal transduction (GO:0002758)	117	41	17.70	+	2.32	1.43E-05	3.43E-04
purine ribonucleoside diphosphate metabolic process (GO:0009179)	63	22	9.53	+	2.31	1.77E-03	2.33E-02
purine nucleoside diphosphate metabolic process (GO:0009135)	63	22	9.53	+	2.31	1.77E-03	2.33E-02
regulation of establishment of planar polarity (GO:0090175)	115	40	17.40	+	2.30	2.09E-05	4.77E-04
DNA-dependent DNA replication (GO:0006261)	141	49	21.33	+	2.30	2.40E-06	6.86E-05
regulation of mRNA stability (GO:0043488)	193	67	29.19	+	2.30	4.74E-08	1.84E-06
negative regulation of mitotic cell cycle phase transition (GO:1901991)	219	76	33.13	+	2.29	5.31E-09	2.46E-07
organic substance catabolic process (GO:1901575)	1782	616	269.55	+	2.29	6.62E-69	5.00E-66
phosphatidylcholine metabolic process (GO:0046470)	81	28	12.25	+	2.29	4.94E-04	7.90E-03
IRE1-mediated unfolded protein response (GO:0036498)	55	19	8.32	+	2.28	3.07E-03	3.74E-02
sterol metabolic process (GO:0016125)	139	48	21.03	+	2.28	3.48E-06	9.64E-05
protein K48-linked ubiquitination (GO:0070936)	58	20	8.77	+	2.28	3.53E-03	4.22E-02
amino acid transmembrane transport (GO:0003333)	87	30	13.16	+	2.28	2.72E-04	4.64E-03
macromolecule catabolic process (GO:0009057)	1060	365	160.34	+	2.28	4.72E-39	1.44E-36
ribonucleoprotein complex localization (GO:0071166)	128	44	19.36	+	2.27	1.13E-05	2.82E-04
ribonucleoside diphosphate metabolic process (GO:0009185)	67	23	10.13	+	2.27	1.43E-03	1.96E-02
electron transport chain (GO:0022900)	178	61	26.92	+	2.27	2.14E-07	7.59E-06
DNA replication (GO:0006260)	225	77	34.03	+	2.26	8.21E-09	3.68E-07
regulation of RNA splicing (GO:0043484)	158	54	23.90	+	2.26	1.10E-06	3.37E-05
monocarboxylic acid biosynthetic process (GO:0072330)	199	68	30.10	+	2.26	4.69E-08	1.83E-06
positive regulation of mitotic cell cycle phase transition (GO:1901992)	82	28	12.40	+	2.26	5.29E-04	8.36E-03
steroid metabolic process (GO:0008202)	258	88	39.03	+	2.25	5.68E-10	3.04E-08
cellular carbohydrate metabolic process (GO:0044262)	176	60	26.62	+	2.25	3.10E-07	1.07E-05
hormone metabolic process (GO:0042445)	197	67	29.80	+	2.25	6.76E-08	2.56E-06
regulation of mRNA catabolic process (GO:0061013)	215	73	32.52	+	2.24	1.91E-08	7.97E-07
ribonucleoprotein complex export from nucleus (GO:0071426)	127	43	19.21	+	2.24	1.78E-05	4.13E-04
cellular catabolic process (GO:0044248)	1830	619	276.81	+	2.24	2.76E-66	1.99E-63
establishment of protein localization to mitochondrion (GO:0072655)	74	25	11.19	+	2.23	1.41E-03	1.94E-02
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	77	26	11.65	+	2.23	1.03E-03	1.48E-02
negative regulation of gene expression, epigenetic (GO:0045814)	77	26	11.65	+	2.23	1.03E-03	1.48E-02
lipid modification (GO:0030258)	234	79	35.40	+	2.23	5.99E-09	2.72E-07
RNA methylation (GO:0001510)	86	29	13.01	+	2.23	4.34E-04	7.02E-03
mRNA export from nucleus (GO:0006406)	110	37	16.64	+	2.22	7.08E-05	1.41E-03
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	110	37	16.64	+	2.22	7.08E-05	1.41E-03
negative regulation of cell cycle phase transition (GO:1901988)	235	79	35.55	+	2.22	9.76E-09	4.30E-07
lipoprotein metabolic process (GO:0042157)	122	41	18.45	+	2.22	3.38E-05	7.39E-04
organic anion transport (GO:0015711)	486	163	73.51	+	2.22	8.01E-17	7.99E-15
regulation of cellular ketone metabolic process (GO:0010565)	197	66	29.80	+	2.21	1.67E-07	6.00E-06
Golgi vesicle transport (GO:0048193)	400	134	60.51	+	2.21	5.69E-14	4.68E-12
cellular lipid catabolic process (GO:0044242)	206	69	31.16	+	2.21	7.34E-08	2.77E-06
catabolic process (GO:0009056)	2103	701	318.11	+	2.20	4.92E-74	4.34E-71
vacuolar transport (GO:0007034)	150	50	22.69	+	2.20	7.02E-06	1.84E-04
protein localization to mitochondrion (GO:0070585)	81	27	12.25	+	2.20	8.30E-04	1.24E-02
cellular nitrogen compound biosynthetic process (GO:0044271)	1578	526	238.69	+	2.20	6.93E-54	3.79E-51
retrograde transport, endosome to Golgi (GO:0042147)	93	31	14.07	+	2.20	4.13E-04	6.74E-03
cellular protein-containing complex assembly (GO:0034622)	824	274	124.64	+	2.20	2.36E-27	4.35E-25
nuclear chromosome segregation (GO:0098813)	217	72	32.82	+	2.19	5.55E-08	2.13E-06
cellular response to hypoxia (GO:0071456)	190	63	28.74	+	2.19	4.52E-07	1.50E-05
macroautophagy (GO:0016236)	190	63	28.74	+	2.19	4.52E-07	1.50E-05
response to unfolded protein (GO:0006986)	169	56	25.56	+	2.19	2.12E-06	6.11E-05
protein import (GO:0017038)	160	53	24.20	+	2.19	3.20E-06	8.95E-05
biosynthetic process (GO:0009058)	2861	947	432.77	+	2.19	5.00E-104	8.82E-101
cellular lipid metabolic process (GO:0044255)	977	323	147.78	+	2.19	9.50E-32	2.19E-29
cellular biosynthetic process (GO:0044249)	2703	893	408.87	+	2.18	1.57E-96	1.91E-93
RNA metabolic process (GO:0016070)	1619	534	244.90	+	2.18	1.19E-53	6.32E-51
organic hydroxy compound biosynthetic process (GO:1901617)	176	58	26.62	+	2.18	1.29E-06	3.86E-05
chromatin organization involved in regulation of transcription (GO:0034401)	88	29	13.31	+	2.18	8.03E-04	1.20E-02
negative regulation of protein ubiquitination (GO:0031397)	79	26	11.95	+	2.18	1.20E-03	1.68E-02
organic substance biosynthetic process (GO:1901576)	2799	921	423.39	+	2.18	2.59E-99	3.42E-96
protein export from nucleus (GO:0006611)	152	50	22.99	+	2.17	7.89E-06	2.05E-04
ubiquitin-dependent ERAD pathway (GO:0030433)	76	25	11.50	+	2.17	1.59E-03	2.16E-02
membrane fusion (GO:0061025)	149	49	22.54	+	2.17	1.05E-05	2.63E-04
protein localization to organelle (GO:0033365)	779	256	117.83	+	2.17	5.58E-25	8.20E-23
negative regulation of DNA recombination (GO:0045910)	64	21	9.68	+	2.17	3.37E-03	4.04E-02
anion transmembrane transport (GO:0098656)	302	99	45.68	+	2.17	3.20E-10	1.77E-08
RNA phosphodiester bond hydrolysis (GO:0090501)	168	55	25.41	+	2.16	3.18E-06	8.91E-05
regulation of mitotic cell cycle phase transition (GO:1901990)	419	137	63.38	+	2.16	1.18E-13	9.26E-12
heterocycle metabolic process (GO:0046483)	2937	958	444.26	+	2.16	1.84E-102	2.91E-99
energy derivation by oxidation of organic compounds (GO:0015980)	230	75	34.79	+	2.16	4.96E-08	1.91E-06
RNA export from nucleus (GO:0006405)	135	44	20.42	+	2.15	3.04E-05	6.72E-04
cellular response to unfolded protein (GO:0034620)	132	43	19.97	+	2.15	3.98E-05	8.55E-04
cellular nitrogen compound metabolic process (GO:0034641)	3405	1109	515.05	+	2.15	1.23E-122	2.78E-119
G1/S transition of mitotic cell cycle (GO:0000082)	129	42	19.51	+	2.15	5.27E-05	1.10E-03
RNA modification (GO:0009451)	172	56	26.02	+	2.15	2.62E-06	7.43E-05
transport across blood-brain barrier (GO:0150104)	86	28	13.01	+	2.15	1.14E-03	1.61E-02
nucleobase-containing compound metabolic process (GO:0006139)	2743	890	414.92	+	2.15	1.32E-92	1.50E-89
positive regulation of viral process (GO:0048524)	111	36	16.79	+	2.14	1.88E-04	3.35E-03
carbohydrate metabolic process (GO:0005975)	494	160	74.72	+	2.14	2.20E-15	2.01E-13
amine metabolic process (GO:0009308)	68	22	10.29	+	2.14	4.16E-03	4.79E-02
post-Golgi vesicle-mediated transport (GO:0006892)	133	43	20.12	+	2.14	4.34E-05	9.22E-04
glycosyl compound metabolic process (GO:1901657)	133	43	20.12	+	2.14	4.34E-05	9.21E-04
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)	99	32	14.98	+	2.14	3.96E-04	6.50E-03
exocytic process (GO:0140029)	65	21	9.83	+	2.14	3.76E-03	4.44E-02
nitrogen compound transport (GO:0071705)	1861	601	281.50	+	2.13	2.06E-58	1.21E-55
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	90	29	13.61	+	2.13	8.98E-04	1.32E-02
vascular transport (GO:0010232)	87	28	13.16	+	2.13	1.20E-03	1.68E-02
organic cyclic compound metabolic process (GO:1901360)	3220	1036	487.07	+	2.13	1.13E-109	2.24E-106
nucleobase-containing small molecule biosynthetic process (GO:0034404)	115	37	17.40	+	2.13	1.56E-04	2.84E-03
cellular aromatic compound metabolic process (GO:0006725)	2987	961	451.82	+	2.13	8.53E-100	1.23E-96
cellular response to decreased oxygen levels (GO:0036294)	199	64	30.10	+	2.13	7.83E-07	2.48E-05
mRNA transport (GO:0051028)	162	52	24.50	+	2.12	9.05E-06	2.30E-04
posttranscriptional regulation of gene expression (GO:0010608)	555	178	83.95	+	2.12	1.15E-16	1.13E-14
cell cycle G1/S phase transition (GO:0044843)	131	42	19.82	+	2.12	6.18E-05	1.27E-03
chromatin assembly (GO:0031497)	147	47	22.24	+	2.11	2.45E-05	5.52E-04
viral process (GO:0016032)	845	270	127.82	+	2.11	8.87E-25	1.29E-22
cellular response to oxygen levels (GO:0071453)	216	69	32.67	+	2.11	3.39E-07	1.16E-05
carbohydrate biosynthetic process (GO:0016051)	138	44	20.87	+	2.11	5.61E-05	1.16E-03
ERAD pathway (GO:0036503)	91	29	13.76	+	2.11	9.68E-04	1.41E-02
protein transport (GO:0015031)	1509	480	228.26	+	2.10	3.40E-44	1.25E-41
DNA repair (GO:0006281)	522	166	78.96	+	2.10	2.71E-15	2.46E-13
gene expression (GO:0010467)	2105	669	318.41	+	2.10	1.37E-63	9.43E-61
endoplasmic reticulum unfolded protein response (GO:0030968)	107	34	16.19	+	2.10	3.80E-04	6.27E-03
DNA packaging (GO:0006323)	192	61	29.04	+	2.10	2.05E-06	5.96E-05
cytosolic transport (GO:0016482)	148	47	22.39	+	2.10	2.69E-05	6.01E-04
chromosome segregation (GO:0007059)	274	87	41.45	+	2.10	1.54E-08	6.58E-07
sulfur compound biosynthetic process (GO:0044272)	186	59	28.14	+	2.10	3.61E-06	9.99E-05
lipid metabolic process (GO:0006629)	1236	392	186.96	+	2.10	1.31E-35	3.41E-33
response to amino acid starvation (GO:1990928)	82	26	12.40	+	2.10	2.30E-03	2.94E-02
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	101	32	15.28	+	2.09	6.70E-04	1.03E-02
regulation of cellular response to heat (GO:1900034)	79	25	11.95	+	2.09	2.09E-03	2.71E-02
vesicle organization (GO:0016050)	313	99	47.35	+	2.09	1.50E-09	7.66E-08
amide transport (GO:0042886)	1575	498	238.24	+	2.09	2.45E-45	9.49E-43
response to topologically incorrect protein (GO:0035966)	190	60	28.74	+	2.09	2.88E-06	8.11E-05
peptide transport (GO:0015833)	1540	485	232.95	+	2.08	7.61E-44	2.75E-41
protein modification by small protein removal (GO:0070646)	296	93	44.77	+	2.08	5.71E-09	2.62E-07
regulation of protein ubiquitination (GO:0031396)	207	65	31.31	+	2.08	1.23E-06	3.74E-05
lipid catabolic process (GO:0016042)	306	96	46.29	+	2.07	3.87E-09	1.87E-07
chromatin assembly or disassembly (GO:0006333)	166	52	25.11	+	2.07	1.76E-05	4.09E-04
nuclear export (GO:0051168)	166	52	25.11	+	2.07	1.76E-05	4.09E-04
protein deubiquitination (GO:0016579)	278	87	42.05	+	2.07	2.02E-08	8.40E-07
RNA localization (GO:0006403)	227	71	34.34	+	2.07	4.12E-07	1.39E-05
intracellular transport (GO:0046907)	1526	477	230.83	+	2.07	2.41E-42	8.49E-40
dicarboxylic acid transport (GO:0006835)	80	25	12.10	+	2.07	3.25E-03	3.92E-02
modification-dependent macromolecule catabolic process (GO:0043632)	557	174	84.25	+	2.07	1.87E-15	1.71E-13
proteolysis involved in cellular protein catabolic process (GO:0051603)	604	188	91.36	+	2.06	1.69E-16	1.65E-14
cellular response to topologically incorrect protein (GO:0035967)	151	47	22.84	+	2.06	4.69E-05	9.88E-04
organic substance transport (GO:0071702)	2229	693	337.17	+	2.06	6.47E-63	4.28E-60
carboxylic acid transport (GO:0046942)	312	97	47.19	+	2.06	5.25E-09	2.44E-07
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	103	32	15.58	+	2.05	7.64E-04	1.15E-02
secondary alcohol metabolic process (GO:1902652)	132	41	19.97	+	2.05	1.56E-04	2.84E-03
mitotic cell cycle phase transition (GO:0044772)	290	90	43.87	+	2.05	1.58E-08	6.71E-07
double-strand break repair via homologous recombination (GO:0000724)	100	31	15.13	+	2.05	1.00E-03	1.45E-02
organic acid transport (GO:0015849)	313	97	47.35	+	2.05	5.53E-09	2.55E-07
anion transport (GO:0006820)	610	189	92.27	+	2.05	2.27E-16	2.21E-14
nucleic acid metabolic process (GO:0090304)	2241	694	338.98	+	2.05	1.31E-62	8.29E-60
regulation of protein modification by small protein conjugation or removal (GO:1903320)	239	74	36.15	+	2.05	3.24E-07	1.11E-05
modification-dependent protein catabolic process (GO:0019941)	546	169	82.59	+	2.05	9.42E-15	8.26E-13
neutrophil degranulation (GO:0043312)	482	149	72.91	+	2.04	3.90E-13	2.98E-11
positive regulation of proteasomal protein catabolic process (GO:1901800)	110	34	16.64	+	2.04	6.97E-04	1.07E-02
cell cycle phase transition (GO:0044770)	298	92	45.08	+	2.04	1.47E-08	6.32E-07
nuclear division (GO:0000280)	305	94	46.14	+	2.04	1.34E-08	5.81E-07
regulation of gene expression, epigenetic (GO:0040029)	172	53	26.02	+	2.04	1.67E-05	3.93E-04
regulation of macroautophagy (GO:0016241)	166	51	25.11	+	2.03	2.80E-05	6.25E-04
cellular monovalent inorganic cation homeostasis (GO:0030004)	114	35	17.24	+	2.03	5.54E-04	8.74E-03
establishment of protein localization (GO:0045184)	1593	489	240.96	+	2.03	1.05E-41	3.55E-39
positive regulation of canonical Wnt signaling pathway (GO:0090263)	150	46	22.69	+	2.03	7.06E-05	1.41E-03
neutrophil activation involved in immune response (GO:0002283)	486	149	73.51	+	2.03	7.13E-13	5.29E-11
neutrophil mediated immunity (GO:0002446)	493	151	74.57	+	2.02	4.57E-13	3.45E-11
monovalent inorganic cation homeostasis (GO:0055067)	147	45	22.24	+	2.02	9.20E-05	1.79E-03
protein localization to membrane (GO:0072657)	526	161	79.56	+	2.02	1.08E-13	8.53E-12
symbiotic process (GO:0044403)	936	286	141.58	+	2.02	9.95E-24	1.37E-21
organelle fission (GO:0048285)	334	102	50.52	+	2.02	4.33E-09	2.04E-07
ATP metabolic process (GO:0046034)	210	64	31.77	+	2.01	3.43E-06	9.55E-05
cellular protein catabolic process (GO:0044257)	637	194	96.35	+	2.01	3.56E-16	3.40E-14
ubiquitin-dependent protein catabolic process (GO:0006511)	539	164	81.53	+	2.01	8.56E-14	6.83E-12
regulation of cell cycle phase transition (GO:1901987)	457	139	69.13	+	2.01	7.85E-12	5.07E-10
recombinational repair (GO:0000725)	102	31	15.43	+	2.01	1.17E-03	1.64E-02
nucleus organization (GO:0006997)	132	40	19.97	+	2.00	2.51E-04	4.32E-03
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	142	43	21.48	+	2.00	1.68E-04	3.02E-03
protein catabolic process (GO:0030163)	691	209	104.52	+	2.00	4.33E-17	4.43E-15
membrane docking (GO:0022406)	179	54	27.08	+	1.99	2.34E-05	5.30E-04
neutrophil activation (GO:0042119)	494	149	74.72	+	1.99	2.39E-12	1.65E-10
phospholipid metabolic process (GO:0006644)	395	119	59.75	+	1.99	3.53E-10	1.94E-08
granulocyte activation (GO:0036230)	498	150	75.33	+	1.99	1.90E-12	1.32E-10
cellular response to interleukin-1 (GO:0071347)	176	53	26.62	+	1.99	3.02E-05	6.68E-04
cellular macromolecule biosynthetic process (GO:0034645)	1636	492	247.47	+	1.99	4.87E-40	1.55E-37
vacuole organization (GO:0007033)	143	43	21.63	+	1.99	1.79E-04	3.21E-03
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	306	92	46.29	+	1.99	4.91E-08	1.90E-06
RNA transport (GO:0050658)	203	61	30.71	+	1.99	8.60E-06	2.21E-04
nucleic acid transport (GO:0050657)	203	61	30.71	+	1.99	8.60E-06	2.21E-04
organelle localization by membrane tethering (GO:0140056)	170	51	25.71	+	1.98	5.10E-05	1.07E-03
nucleoside metabolic process (GO:0009116)	107	32	16.19	+	1.98	1.43E-03	1.96E-02
organonitrogen compound catabolic process (GO:1901565)	1088	325	164.57	+	1.97	1.15E-25	1.78E-23
carbohydrate derivative biosynthetic process (GO:1901137)	616	184	93.18	+	1.97	8.87E-15	7.81E-13
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	134	40	20.27	+	1.97	4.04E-04	6.63E-03
establishment of RNA localization (GO:0051236)	205	61	31.01	+	1.97	9.93E-06	2.50E-04
positive regulation of mitotic cell cycle (GO:0045931)	111	33	16.79	+	1.97	1.16E-03	1.63E-02
response to heat (GO:0009408)	101	30	15.28	+	1.96	2.50E-03	3.14E-02
nucleocytoplasmic transport (GO:0006913)	266	79	40.24	+	1.96	7.21E-07	2.30E-05
glycerophospholipid metabolic process (GO:0006650)	330	98	49.92	+	1.96	2.82E-08	1.14E-06
negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	91	27	13.76	+	1.96	3.67E-03	4.34E-02
carbohydrate derivative metabolic process (GO:1901135)	1020	302	154.29	+	1.96	2.41E-23	3.30E-21
transition metal ion transport (GO:0000041)	125	37	18.91	+	1.96	6.34E-04	9.84E-03
myeloid leukocyte mediated immunity (GO:0002444)	514	152	77.75	+	1.95	3.94E-12	2.65E-10
leukocyte degranulation (GO:0043299)	504	149	76.24	+	1.95	8.33E-12	5.35E-10
protein-containing complex assembly (GO:0065003)	1302	384	196.95	+	1.95	1.82E-29	3.66E-27
macromolecule biosynthetic process (GO:0009059)	1682	496	254.43	+	1.95	1.92E-38	5.75E-36
negative regulation of cell cycle process (GO:0010948)	329	97	49.77	+	1.95	4.07E-08	1.62E-06
DNA recombination (GO:0006310)	224	66	33.88	+	1.95	6.47E-06	1.70E-04
mitotic prometaphase (GO:0000236)	170	50	25.71	+	1.94	8.08E-05	1.59E-03
nuclear transport (GO:0051169)	269	79	40.69	+	1.94	8.35E-07	2.62E-05
regulation of signal transduction by p53 class mediator (GO:1901796)	181	53	27.38	+	1.94	5.70E-05	1.18E-03
cholesterol metabolic process (GO:0008203)	123	36	18.61	+	1.93	8.81E-04	1.30E-02
positive regulation of translation (GO:0045727)	137	40	20.72	+	1.93	4.80E-04	7.72E-03
activation of innate immune response (GO:0002218)	144	42	21.78	+	1.93	4.18E-04	6.81E-03
protein polyubiquitination (GO:0000209)	326	95	49.31	+	1.93	8.19E-08	3.06E-06
regulation of DNA recombination (GO:0000018)	127	37	19.21	+	1.93	1.01E-03	1.45E-02
DNA metabolic process (GO:0006259)	769	224	116.32	+	1.93	1.08E-16	1.07E-14
membrane lipid metabolic process (GO:0006643)	206	60	31.16	+	1.93	2.22E-05	5.06E-04
myeloid cell activation involved in immune response (GO:0002275)	519	151	78.51	+	1.92	1.54E-11	9.71E-10
respiratory electron transport chain (GO:0022904)	110	32	16.64	+	1.92	2.47E-03	3.11E-02
regulation of gene silencing (GO:0060968)	117	34	17.70	+	1.92	1.49E-03	2.03E-02
positive regulation of cell cycle phase transition (GO:1901989)	100	29	15.13	+	1.92	3.61E-03	4.30E-02
organic cyclic compound biosynthetic process (GO:1901362)	1233	357	186.51	+	1.91	4.31E-26	7.12E-24
chromosome organization (GO:0051276)	1063	307	160.79	+	1.91	2.98E-22	3.81E-20
regulation of translation (GO:0006417)	374	108	56.57	+	1.91	1.69E-08	7.07E-07
regulation of cellular amide metabolic process (GO:0034248)	433	125	65.50	+	1.91	1.19E-09	6.13E-08
phosphatidylinositol biosynthetic process (GO:0006661)	111	32	16.79	+	1.91	2.56E-03	3.19E-02
positive regulation of protein ubiquitination (GO:0031398)	122	35	18.45	+	1.90	1.82E-03	2.40E-02
heterocycle biosynthetic process (GO:0018130)	1085	311	164.12	+	1.89	3.35E-22	4.26E-20
tumor necrosis factor-mediated signaling pathway (GO:0033209)	126	36	19.06	+	1.89	1.45E-03	1.98E-02
protein maturation (GO:0051604)	238	68	36.00	+	1.89	1.14E-05	2.83E-04
transmembrane transport (GO:0055085)	1303	372	197.10	+	1.89	2.72E-26	4.59E-24
protein stabilization (GO:0050821)	193	55	29.19	+	1.88	9.02E-05	1.77E-03
sphingolipid metabolic process (GO:0006665)	158	45	23.90	+	1.88	3.49E-04	5.80E-03
Golgi organization (GO:0007030)	137	39	20.72	+	1.88	1.02E-03	1.47E-02
autophagy (GO:0006914)	306	87	46.29	+	1.88	7.74E-07	2.46E-05
process utilizing autophagic mechanism (GO:0061919)	306	87	46.29	+	1.88	7.74E-07	2.46E-05
cellular response to insulin stimulus (GO:0032869)	176	50	26.62	+	1.88	2.15E-04	3.78E-03
negative regulation of mitotic cell cycle (GO:0045930)	303	86	45.83	+	1.88	1.00E-06	3.07E-05
protein-containing complex subunit organization (GO:0043933)	1547	439	234.00	+	1.88	1.37E-30	2.94E-28
response to interleukin-1 (GO:0070555)	201	57	30.40	+	1.87	8.42E-05	1.65E-03
regulation of mitotic cell cycle (GO:0007346)	597	168	90.30	+	1.86	9.73E-12	6.20E-10
endosomal transport (GO:0016197)	235	66	35.55	+	1.86	2.22E-05	5.05E-04
glycerolipid metabolic process (GO:0046486)	399	112	60.35	+	1.86	3.06E-08	1.24E-06
cellular response to starvation (GO:0009267)	196	55	29.65	+	1.86	1.06E-04	2.01E-03
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	164	46	24.81	+	1.85	4.30E-04	6.97E-03
DNA biosynthetic process (GO:0071897)	118	33	17.85	+	1.85	3.37E-03	4.04E-02
cellular modified amino acid metabolic process (GO:0006575)	186	52	28.14	+	1.85	2.14E-04	3.77E-03
mitotic cell cycle (GO:0000278)	757	211	114.51	+	1.84	3.15E-14	2.66E-12
establishment of vesicle localization (GO:0051650)	201	56	30.40	+	1.84	1.22E-04	2.29E-03
mitotic cell cycle process (GO:1903047)	680	189	102.86	+	1.84	1.06E-12	7.75E-11
regulation of small molecule metabolic process (GO:0062012)	457	127	69.13	+	1.84	6.08E-09	2.75E-07
regulation of proteasomal protein catabolic process (GO:0061136)	184	51	27.83	+	1.83	2.89E-04	4.91E-03
nucleobase-containing compound biosynthetic process (GO:0034654)	1012	280	153.08	+	1.83	2.96E-18	3.09E-16
gene silencing (GO:0016458)	152	42	22.99	+	1.83	8.87E-04	1.31E-02
amino acid transport (GO:0006865)	134	37	20.27	+	1.83	1.98E-03	2.59E-02
membrane lipid biosynthetic process (GO:0046467)	134	37	20.27	+	1.83	1.98E-03	2.58E-02
aromatic compound biosynthetic process (GO:0019438)	1096	302	165.79	+	1.82	1.99E-19	2.16E-17
response to endoplasmic reticulum stress (GO:0034976)	262	72	39.63	+	1.82	1.89E-05	4.33E-04
viral life cycle (GO:0019058)	223	61	33.73	+	1.81	8.93E-05	1.75E-03
cellular macromolecule localization (GO:0070727)	1652	451	249.89	+	1.80	2.20E-28	4.25E-26
cellular protein localization (GO:0034613)	1643	448	248.53	+	1.80	3.60E-28	6.79E-26
establishment of localization in cell (GO:0051649)	2378	647	359.71	+	1.80	1.27E-41	4.19E-39
protein methylation (GO:0006479)	140	38	21.18	+	1.79	2.41E-03	3.04E-02
protein alkylation (GO:0008213)	140	38	21.18	+	1.79	2.41E-03	3.04E-02
negative regulation of cellular amide metabolic process (GO:0034249)	155	42	23.45	+	1.79	1.36E-03	1.89E-02
response to insulin (GO:0032868)	240	65	36.30	+	1.79	7.55E-05	1.49E-03
double-strand break repair (GO:0006302)	189	51	28.59	+	1.78	4.88E-04	7.82E-03
vesicle localization (GO:0051648)	208	56	31.46	+	1.78	2.31E-04	4.00E-03
T cell receptor signaling pathway (GO:0050852)	182	49	27.53	+	1.78	5.73E-04	8.97E-03
cellular metabolic process (GO:0044237)	7784	2095	1177.44	+	1.78	3.34E-207	2.65E-203
positive regulation of cellular amide metabolic process (GO:0034250)	168	45	25.41	+	1.77	1.05E-03	1.50E-02
Fc receptor signaling pathway (GO:0038093)	239	64	36.15	+	1.77	1.04E-04	1.99E-03
positive regulation of Wnt signaling pathway (GO:0030177)	183	49	27.68	+	1.77	8.10E-04	1.21E-02
response to drug (GO:0042493)	393	105	59.45	+	1.77	8.11E-07	2.55E-05
phosphorus metabolic process (GO:0006793)	2197	585	332.33	+	1.76	5.40E-35	1.36E-32
cellular response to chemical stress (GO:0062197)	290	77	43.87	+	1.76	3.18E-05	6.99E-04
myeloid leukocyte activation (GO:0002274)	584	155	88.34	+	1.75	1.83E-09	9.25E-08
mitotic spindle organization (GO:0007052)	166	44	25.11	+	1.75	1.41E-03	1.94E-02
cellular response to stress (GO:0033554)	1761	466	266.38	+	1.75	7.85E-27	1.37E-24
response to hypoxia (GO:0001666)	344	91	52.03	+	1.75	5.50E-06	1.47E-04
phosphate-containing compound metabolic process (GO:0006796)	2170	574	328.24	+	1.75	1.34E-33	3.23E-31
cellular response to DNA damage stimulus (GO:0006974)	787	208	119.04	+	1.75	3.65E-12	2.47E-10
primary metabolic process (GO:0044238)	7578	1992	1146.28	+	1.74	1.19E-176	4.72E-173
cellular response to oxidative stress (GO:0034599)	244	64	36.91	+	1.73	1.70E-04	3.06E-03
protein-containing complex disassembly (GO:0032984)	225	59	34.03	+	1.73	3.67E-04	6.08E-03
DNA integrity checkpoint (GO:0031570)	149	39	22.54	+	1.73	3.27E-03	3.94E-02
cell division (GO:0051301)	501	131	75.78	+	1.73	8.80E-08	3.26E-06
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)	218	57	32.98	+	1.73	4.24E-04	6.89E-03
cell cycle checkpoint (GO:0000075)	199	52	30.10	+	1.73	9.22E-04	1.35E-02
protein localization (GO:0008104)	2198	573	332.48	+	1.72	4.75E-32	1.11E-29
regulation of chromosome organization (GO:0033044)	284	74	42.96	+	1.72	7.17E-05	1.42E-03
leukocyte activation involved in immune response (GO:0002366)	622	162	94.09	+	1.72	2.64E-09	1.31E-07
post-translational protein modification (GO:0043687)	361	94	54.61	+	1.72	6.43E-06	1.70E-04
organic substance metabolic process (GO:0071704)	8011	2085	1211.77	+	1.72	1.48E-187	7.81E-184
Fc-epsilon receptor signaling pathway (GO:0038095)	173	45	26.17	+	1.72	1.73E-03	2.30E-02
regulation of cell cycle process (GO:0010564)	769	200	116.32	+	1.72	4.11E-11	2.46E-09
positive regulation of intracellular protein transport (GO:0090316)	185	48	27.98	+	1.72	1.67E-03	2.24E-02
cell activation involved in immune response (GO:0002263)	626	162	94.69	+	1.71	4.00E-09	1.91E-07
cellular component biogenesis (GO:0044085)	2654	685	401.45	+	1.71	5.68E-38	1.67E-35
negative regulation of canonical Wnt signaling pathway (GO:0090090)	186	48	28.14	+	1.71	1.72E-03	2.29E-02
metabolic process (GO:0008152)	8592	2217	1299.66	+	1.71	1.89E-207	3.00E-203
spindle organization (GO:0007051)	229	59	34.64	+	1.70	4.26E-04	6.91E-03
response to starvation (GO:0042594)	241	62	36.45	+	1.70	4.09E-04	6.70E-03
response to oxygen levels (GO:0070482)	382	98	57.78	+	1.70	7.94E-06	2.06E-04
organelle localization (GO:0051640)	612	157	92.57	+	1.70	1.34E-08	5.81E-07
response to temperature stimulus (GO:0009266)	168	43	25.41	+	1.69	2.89E-03	3.54E-02
response to decreased oxygen levels (GO:0036293)	356	91	53.85	+	1.69	1.96E-05	4.49E-04
macromolecule localization (GO:0033036)	2561	654	387.39	+	1.69	7.22E-35	1.79E-32
exocytosis (GO:0006887)	788	201	119.20	+	1.69	1.25E-10	7.34E-09
nitrogen compound metabolic process (GO:0006807)	7091	1807	1072.61	+	1.68	2.05E-135	5.42E-132
regulated exocytosis (GO:0045055)	691	176	104.52	+	1.68	2.26E-09	1.13E-07
methylation (GO:0032259)	319	81	48.25	+	1.68	6.83E-05	1.37E-03
establishment of organelle localization (GO:0051656)	398	101	60.20	+	1.68	8.64E-06	2.21E-04
regulation of protein stability (GO:0031647)	304	77	45.98	+	1.67	1.19E-04	2.24E-03
regulation of generation of precursor metabolites and energy (GO:0043467)	166	42	25.11	+	1.67	3.81E-03	4.48E-02
macromolecule methylation (GO:0043414)	261	66	39.48	+	1.67	3.61E-04	5.98E-03
regulation of DNA metabolic process (GO:0051052)	380	96	57.48	+	1.67	1.44E-05	3.43E-04
mitochondrion organization (GO:0007005)	465	117	70.34	+	1.66	2.05E-06	5.97E-05
negative regulation of cell cycle (GO:0045786)	577	145	87.28	+	1.66	1.23E-07	4.46E-06
meiotic cell cycle (GO:0051321)	227	57	34.34	+	1.66	1.01E-03	1.45E-02
cellular response to nutrient levels (GO:0031669)	243	61	36.76	+	1.66	7.97E-04	1.20E-02
positive regulation of intracellular transport (GO:0032388)	228	57	34.49	+	1.65	1.05E-03	1.50E-02
positive regulation of DNA metabolic process (GO:0051054)	209	52	31.61	+	1.64	2.21E-03	2.85E-02
protein glycosylation (GO:0006486)	246	61	37.21	+	1.64	8.61E-04	1.28E-02
macromolecule glycosylation (GO:0043413)	246	61	37.21	+	1.64	8.61E-04	1.28E-02
regulation of cellular catabolic process (GO:0031329)	866	214	130.99	+	1.63	3.90E-10	2.13E-08
glycosylation (GO:0070085)	259	64	39.18	+	1.63	6.49E-04	1.00E-02
regulation of intracellular transport (GO:0032386)	365	90	55.21	+	1.63	6.01E-05	1.24E-03
cellular localization (GO:0051641)	3005	740	454.55	+	1.63	1.79E-35	4.58E-33
regulation of cellular protein catabolic process (GO:1903362)	252	62	38.12	+	1.63	9.75E-04	1.42E-02
cellular component disassembly (GO:0022411)	400	98	60.51	+	1.62	3.92E-05	8.45E-04
cell cycle process (GO:0022402)	1059	259	160.19	+	1.62	8.71E-12	5.57E-10
positive regulation of innate immune response (GO:0045089)	209	51	31.61	+	1.61	3.02E-03	3.68E-02
organonitrogen compound metabolic process (GO:1901564)	5444	1323	823.48	+	1.61	3.85E-71	3.05E-68
response to oxidative stress (GO:0006979)	400	97	60.51	+	1.60	5.29E-05	1.11E-03
regulation of cell cycle (GO:0051726)	1209	290	182.88	+	1.59	2.93E-12	2.00E-10
cell cycle (GO:0007049)	1383	331	209.20	+	1.58	8.89E-14	7.05E-12
regulation of catabolic process (GO:0009894)	1029	246	155.65	+	1.58	2.36E-10	1.33E-08
regulation of protein catabolic process (GO:0042176)	394	94	59.60	+	1.58	1.39E-04	2.58E-03
response to toxic substance (GO:0009636)	239	57	36.15	+	1.58	3.08E-03	3.75E-02
dephosphorylation (GO:0016311)	323	77	48.86	+	1.58	5.59E-04	8.79E-03
positive regulation of protein-containing complex assembly (GO:0031334)	252	60	38.12	+	1.57	2.29E-03	2.92E-02
proteolysis (GO:0006508)	1297	308	196.19	+	1.57	1.57E-12	1.11E-10
cellular protein metabolic process (GO:0044267)	3822	905	578.13	+	1.57	3.41E-39	1.06E-36
transport (GO:0006810)	4574	1082	691.88	+	1.56	6.06E-49	2.67E-46
chromatin organization (GO:0006325)	704	166	106.49	+	1.56	4.92E-07	1.62E-05
ion transmembrane transport (GO:0034220)	921	216	139.31	+	1.55	1.26E-08	5.48E-07
establishment of localization (GO:0051234)	4713	1101	712.91	+	1.54	9.58E-48	4.00E-45
cellular response to extracellular stimulus (GO:0031668)	274	64	41.45	+	1.54	2.58E-03	3.21E-02
macromolecule metabolic process (GO:0043170)	6333	1476	957.95	+	1.54	9.01E-72	7.52E-69
cellular macromolecule metabolic process (GO:0044260)	5145	1194	778.25	+	1.53	6.96E-52	3.25E-49
response to metal ion (GO:0010038)	371	86	56.12	+	1.53	5.80E-04	9.07E-03
protein-containing complex localization (GO:0031503)	255	59	38.57	+	1.53	4.15E-03	4.78E-02
cellular component assembly (GO:0022607)	2394	553	362.13	+	1.53	2.50E-20	2.83E-18
response to inorganic substance (GO:0010035)	542	125	81.98	+	1.52	3.44E-05	7.49E-04
secretion by cell (GO:0032940)	977	225	147.78	+	1.52	2.32E-08	9.55E-07
positive regulation of cellular protein localization (GO:1903829)	304	70	45.98	+	1.52	1.98E-03	2.58E-02
ion transport (GO:0006811)	1348	310	203.90	+	1.52	3.59E-11	2.16E-09
secretion (GO:0046903)	1093	251	165.33	+	1.52	4.03E-09	1.90E-07
response to nutrient levels (GO:0031667)	502	115	75.93	+	1.51	1.05E-04	1.99E-03
organelle organization (GO:0006996)	3586	820	542.43	+	1.51	2.26E-30	4.77E-28
protein modification by small protein conjugation (GO:0032446)	822	187	124.34	+	1.50	8.53E-07	2.67E-05
protein modification by small protein conjugation or removal (GO:0070647)	1033	234	156.26	+	1.50	4.03E-08	1.60E-06
export from cell (GO:0140352)	1025	232	155.05	+	1.50	4.58E-08	1.79E-06
membrane organization (GO:0061024)	921	208	139.31	+	1.49	2.49E-07	8.73E-06
cell-cell signaling by wnt (GO:0198738)	346	78	52.34	+	1.49	2.23E-03	2.86E-02
Wnt signaling pathway (GO:0016055)	346	78	52.34	+	1.49	2.23E-03	2.86E-02
response to extracellular stimulus (GO:0009991)	534	120	80.77	+	1.49	1.30E-04	2.42E-03
positive regulation of establishment of protein localization (GO:1904951)	374	84	56.57	+	1.48	1.61E-03	2.17E-02
organelle assembly (GO:0070925)	773	173	116.93	+	1.48	4.64E-06	1.26E-04
regulation of cellular protein localization (GO:1903827)	568	127	85.92	+	1.48	1.01E-04	1.94E-03
protein ubiquitination (GO:0016567)	744	166	112.54	+	1.48	8.10E-06	2.09E-04
endomembrane system organization (GO:0010256)	453	101	68.52	+	1.47	5.70E-04	8.94E-03
regulation of autophagy (GO:0010506)	342	76	51.73	+	1.47	3.37E-03	4.04E-02
protein metabolic process (GO:0019538)	4407	974	666.62	+	1.46	2.23E-32	5.29E-30
lipid localization (GO:0010876)	350	77	52.94	+	1.45	3.74E-03	4.42E-02
vesicle-mediated transport (GO:0016192)	1972	432	298.29	+	1.45	1.36E-12	9.72E-11
phosphorylation (GO:0016310)	1301	282	196.79	+	1.43	4.26E-08	1.68E-06
regulation of protein-containing complex assembly (GO:0043254)	459	99	69.43	+	1.43	1.83E-03	2.41E-02
monovalent inorganic cation transport (GO:0015672)	422	91	63.83	+	1.43	2.87E-03	3.51E-02
leukocyte mediated immunity (GO:0002443)	760	163	114.96	+	1.42	6.75E-05	1.36E-03
peptidyl-amino acid modification (GO:0018193)	898	192	135.83	+	1.41	1.55E-05	3.67E-04
response to abiotic stimulus (GO:0009628)	1165	249	176.22	+	1.41	8.53E-07	2.67E-05
positive regulation of organelle organization (GO:0010638)	608	129	91.97	+	1.40	5.81E-04	9.08E-03
cation transport (GO:0006812)	835	174	126.31	+	1.38	1.36E-04	2.53E-03
RNA biosynthetic process (GO:0032774)	570	118	86.22	+	1.37	2.35E-03	2.99E-02
localization (GO:0051179)	5873	1215	888.37	+	1.37	3.26E-31	7.18E-29
regulation of cellular localization (GO:0060341)	848	175	128.27	+	1.36	2.18E-04	3.81E-03
cation transmembrane transport (GO:0098655)	636	131	96.20	+	1.36	1.59E-03	2.16E-02
macromolecule modification (GO:0043412)	3412	701	516.11	+	1.36	2.71E-15	2.45E-13
cellular protein modification process (GO:0006464)	3188	644	482.23	+	1.34	1.17E-12	8.53E-11
protein modification process (GO:0036211)	3188	644	482.23	+	1.34	1.17E-12	8.49E-11
cellular component organization or biogenesis (GO:0071840)	5922	1195	895.78	+	1.33	1.64E-26	2.80E-24
leukocyte activation (GO:0045321)	931	187	140.83	+	1.33	4.01E-04	6.58E-03
regulation of organelle organization (GO:0033043)	1211	242	183.18	+	1.32	7.13E-05	1.42E-03
immune effector process (GO:0002252)	1095	215	165.63	+	1.30	4.72E-04	7.60E-03
response to organonitrogen compound (GO:0010243)	1001	194	151.41	+	1.28	1.55E-03	2.10E-02
interspecies interaction between organisms (GO:0044419)	2129	412	322.04	+	1.28	2.29E-06	6.58E-05
cellular component organization (GO:0016043)	5703	1083	862.66	+	1.26	1.37E-15	1.27E-13
cell activation (GO:0001775)	1076	203	162.76	+	1.25	3.79E-03	4.46E-02
cellular process (GO:0009987)	15598	2938	2359.41	+	1.25	4.04E-143	1.28E-139
response to organic substance (GO:0010033)	3013	553	455.76	+	1.21	8.15E-06	2.10E-04
response to stress (GO:0006950)	3663	672	554.08	+	1.21	5.86E-07	1.90E-05
cellular response to chemical stimulus (GO:0070887)	2932	537	443.51	+	1.21	1.54E-05	3.64E-04
regulation of biological quality (GO:0065008)	4033	738	610.05	+	1.21	1.76E-07	6.28E-06
regulation of cellular component organization (GO:0051128)	2373	422	358.95	+	1.18	1.29E-03	1.79E-02
biological_process (GO:0008150)	18012	3063	2724.56	+	1.12	3.86E-87	3.83E-84
regulation of biological process (GO:0050789)	11960	1686	1809.11	-	.93	3.97E-05	8.53E-04
regulation of cellular process (GO:0050794)	11395	1552	1723.65	-	.90	1.23E-08	5.38E-07
developmental process (GO:0032502)	5765	753	872.04	-	.86	7.83E-06	2.04E-04
regulation of RNA metabolic process (GO:0051252)	3801	490	574.95	-	.85	2.02E-04	3.58E-03
regulation of signaling (GO:0023051)	3479	440	526.25	-	.84	9.41E-05	1.83E-03
regulation of cell communication (GO:0010646)	3443	432	520.80	-	.83	5.06E-05	1.06E-03
regulation of signal transduction (GO:0009966)	3078	383	465.59	-	.82	7.95E-05	1.56E-03
anatomical structure development (GO:0048856)	5301	657	801.85	-	.82	1.67E-08	7.01E-07
positive regulation of gene expression (GO:0010628)	2302	284	348.21	-	.82	4.95E-04	7.89E-03
immune response (GO:0006955)	1952	240	295.27	-	.81	1.29E-03	1.79E-02
regulation of response to stimulus (GO:0048583)	4287	527	648.47	-	.81	3.23E-07	1.11E-05
multicellular organismal process (GO:0032501)	6985	856	1056.58	-	.81	7.06E-13	5.26E-11
multicellular organism development (GO:0007275)	4906	597	742.10	-	.80	5.79E-09	2.65E-07
negative regulation of response to stimulus (GO:0048585)	1824	219	275.91	-	.79	6.11E-04	9.51E-03
regulation of cell differentiation (GO:0045595)	1574	187	238.09	-	.79	9.66E-04	1.40E-02
regulation of response to external stimulus (GO:0032101)	1204	142	182.12	-	.78	3.62E-03	4.30E-02
regulation of protein phosphorylation (GO:0001932)	1468	171	222.06	-	.77	6.44E-04	9.96E-03
regulation of nucleic acid-templated transcription (GO:1903506)	3521	410	532.60	-	.77	2.04E-08	8.46E-07
positive regulation of response to stimulus (GO:0048584)	2303	268	348.36	-	.77	1.12E-05	2.80E-04
regulation of RNA biosynthetic process (GO:2001141)	3526	410	533.36	-	.77	1.55E-08	6.59E-07
system development (GO:0048731)	4317	501	653.01	-	.77	1.32E-10	7.71E-09
negative regulation of nucleic acid-templated transcription (GO:1903507)	1310	152	198.16	-	.77	1.20E-03	1.68E-02
cell-cell signaling (GO:0007267)	1122	130	169.72	-	.77	2.61E-03	3.23E-02
negative regulation of RNA biosynthetic process (GO:1902679)	1312	152	198.46	-	.77	1.05E-03	1.50E-02
regulation of transcription, DNA-templated (GO:0006355)	3452	398	522.16	-	.76	9.76E-09	4.31E-07
regulation of immune response (GO:0050776)	1137	131	171.99	-	.76	2.08E-03	2.70E-02
regulation of developmental process (GO:0050793)	2469	284	373.47	-	.76	1.83E-06	5.35E-05
regulation of immune system process (GO:0002682)	1708	196	258.36	-	.76	9.88E-05	1.91E-03
response to biotic stimulus (GO:0009607)	1466	168	221.75	-	.76	3.09E-04	5.22E-03
animal organ development (GO:0048513)	3247	372	491.15	-	.76	1.46E-08	6.28E-07
positive regulation of immune system process (GO:0002684)	1054	120	159.43	-	.75	2.21E-03	2.84E-02
response to other organism (GO:0051707)	1431	162	216.46	-	.75	2.25E-04	3.92E-03
response to external biotic stimulus (GO:0043207)	1433	162	216.76	-	.75	1.95E-04	3.47E-03
positive regulation of RNA metabolic process (GO:0051254)	1722	194	260.48	-	.74	3.12E-05	6.88E-04
positive regulation of intracellular signal transduction (GO:1902533)	1017	113	153.84	-	.73	1.14E-03	1.61E-02
negative regulation of transcription, DNA-templated (GO:0045892)	1270	141	192.10	-	.73	2.16E-04	3.78E-03
positive regulation of cell population proliferation (GO:0008284)	941	104	142.34	-	.73	1.44E-03	1.97E-02
cellular developmental process (GO:0048869)	3596	397	543.94	-	.73	1.67E-11	1.04E-09
regulation of multicellular organismal process (GO:0051239)	2698	297	408.11	-	.73	9.84E-09	4.31E-07
cell communication (GO:0007154)	5611	609	848.74	-	.72	1.28E-20	1.48E-18
embryo development (GO:0009790)	996	108	150.66	-	.72	5.21E-04	8.25E-03
cell differentiation (GO:0030154)	3540	383	535.47	-	.72	1.90E-12	1.32E-10
regulation of MAPK cascade (GO:0043408)	705	76	106.64	-	.71	3.59E-03	4.28E-02
nervous system development (GO:0007399)	2203	237	333.23	-	.71	5.12E-08	1.97E-06
positive regulation of multicellular organismal process (GO:0051240)	1431	153	216.46	-	.71	1.32E-05	3.21E-04
regulation of cell population proliferation (GO:0042127)	1667	178	252.16	-	.71	2.10E-06	6.10E-05
signal transduction (GO:0007165)	5168	548	781.73	-	.70	6.95E-21	8.16E-19
cell surface receptor signaling pathway (GO:0007166)	2520	267	381.18	-	.70	1.09E-09	5.63E-08
signaling (GO:0023052)	5520	582	834.98	-	.70	3.40E-23	4.61E-21
positive regulation of phosphorus metabolic process (GO:0010562)	1165	122	176.22	-	.69	3.78E-05	8.15E-04
positive regulation of phosphate metabolic process (GO:0045937)	1165	122	176.22	-	.69	3.78E-05	8.14E-04
hemopoiesis (GO:0030097)	587	61	88.79	-	.69	3.80E-03	4.47E-02
positive regulation of nucleic acid-templated transcription (GO:1903508)	1627	168	246.11	-	.68	3.48E-07	1.19E-05
positive regulation of RNA biosynthetic process (GO:1902680)	1628	168	246.26	-	.68	3.49E-07	1.19E-05
positive regulation of cell motility (GO:2000147)	546	56	82.59	-	.68	4.02E-03	4.64E-02
response to bacterium (GO:0009617)	733	75	110.88	-	.68	6.84E-04	1.05E-02
positive regulation of transcription, DNA-templated (GO:0045893)	1542	157	233.25	-	.67	3.15E-07	1.08E-05
positive regulation of locomotion (GO:0040017)	561	57	84.86	-	.67	3.05E-03	3.71E-02
positive regulation of phosphorylation (GO:0042327)	1094	111	165.48	-	.67	1.75E-05	4.07E-04
regulation of cell migration (GO:0030334)	894	90	135.23	-	.67	9.19E-05	1.79E-03
regulation of cellular component movement (GO:0051270)	1037	104	156.86	-	.66	1.92E-05	4.40E-04
cell development (GO:0048468)	1655	165	250.34	-	.66	2.55E-08	1.04E-06
positive regulation of developmental process (GO:0051094)	1278	127	193.32	-	.66	1.20E-06	3.65E-05
regulation of locomotion (GO:0040012)	998	98	150.96	-	.65	1.30E-05	3.18E-04
regulation of cell motility (GO:2000145)	956	93	144.61	-	.64	1.32E-05	3.21E-04
positive regulation of protein phosphorylation (GO:0001934)	1017	98	153.84	-	.64	4.34E-06	1.18E-04
regulation of GTPase activity (GO:0043087)	488	47	73.82	-	.64	1.86E-03	2.44E-02
sensory organ development (GO:0007423)	572	55	86.52	-	.64	7.67E-04	1.15E-02
regulation of transcription by RNA polymerase II (GO:0006357)	2629	252	397.67	-	.63	8.73E-15	7.73E-13
cell projection organization (GO:0030030)	1200	115	181.52	-	.63	4.36E-07	1.45E-05
defense response (GO:0006952)	1433	137	216.76	-	.63	2.39E-08	9.80E-07
regulation of system process (GO:0044057)	586	56	88.64	-	.63	5.71E-04	8.94E-03
regulation of multicellular organismal development (GO:2000026)	1332	127	201.48	-	.63	6.25E-08	2.38E-06
neurogenesis (GO:0022008)	1401	133	211.92	-	.63	2.13E-08	8.80E-07
negative regulation of cell population proliferation (GO:0008285)	699	66	105.73	-	.62	1.07E-04	2.03E-03
plasma membrane bounded cell projection organization (GO:0120036)	1154	108	174.56	-	.62	2.55E-07	8.92E-06
negative regulation of transcription by RNA polymerase II (GO:0000122)	924	86	139.77	-	.62	3.64E-06	1.00E-04
cellular component morphogenesis (GO:0032989)	617	57	93.33	-	.61	1.62E-04	2.93E-03
generation of neurons (GO:0048699)	1278	118	193.32	-	.61	2.05E-08	8.47E-07
defense response to other organism (GO:0098542)	1040	96	157.31	-	.61	5.43E-07	1.77E-05
innate immune response (GO:0045087)	847	78	128.12	-	.61	5.95E-06	1.58E-04
forebrain development (GO:0030900)	402	37	60.81	-	.61	2.65E-03	3.28E-02
circulatory system development (GO:0072359)	871	80	131.75	-	.61	3.92E-06	1.07E-04
blood circulation (GO:0008015)	406	37	61.41	-	.60	1.76E-03	2.33E-02
positive regulation of GTPase activity (GO:0043547)	418	38	63.23	-	.60	1.58E-03	2.15E-02
positive regulation of cell differentiation (GO:0045597)	837	76	126.61	-	.60	4.08E-06	1.12E-04
epithelial cell differentiation (GO:0030855)	683	62	103.31	-	.60	3.44E-05	7.49E-04
system process (GO:0003008)	2066	187	312.51	-	.60	6.48E-14	5.24E-12
tissue development (GO:0009888)	1763	158	266.68	-	.59	2.61E-12	1.79E-10
positive regulation of MAPK cascade (GO:0043410)	526	47	79.56	-	.59	2.14E-04	3.77E-03
anatomical structure morphogenesis (GO:0009653)	2182	194	330.06	-	.59	1.65E-15	1.52E-13
regulation of cell development (GO:0060284)	495	44	74.88	-	.59	2.96E-04	5.01E-03
regulation of neurogenesis (GO:0050767)	360	32	54.45	-	.59	2.48E-03	3.12E-02
neuron development (GO:0048666)	850	75	128.57	-	.58	1.34E-06	4.00E-05
negative regulation of multicellular organismal process (GO:0051241)	1022	90	154.59	-	.58	7.43E-08	2.79E-06
neuron differentiation (GO:0030182)	1050	92	158.83	-	.58	3.91E-08	1.56E-06
movement of cell or subcellular component (GO:0006928)	1599	140	241.87	-	.58	5.89E-12	3.87E-10
cellular divalent inorganic cation homeostasis (GO:0072503)	460	40	69.58	-	.57	3.71E-04	6.12E-03
skin development (GO:0043588)	381	33	57.63	-	.57	1.19E-03	1.66E-02
regulation of immune effector process (GO:0002697)	474	41	71.70	-	.57	2.70E-04	4.62E-03
regulation of cellular response to growth factor stimulus (GO:0090287)	302	26	45.68	-	.57	3.84E-03	4.51E-02
skeletal system development (GO:0001501)	489	42	73.97	-	.57	1.57E-04	2.86E-03
heart development (GO:0007507)	524	45	79.26	-	.57	9.28E-05	1.80E-03
epithelium development (GO:0060429)	1121	96	169.57	-	.57	4.59E-09	2.16E-07
epidermis development (GO:0008544)	423	36	63.98	-	.56	4.58E-04	7.38E-03
behavior (GO:0007610)	577	49	87.28	-	.56	3.25E-05	7.12E-04
neuron projection development (GO:0031175)	695	59	105.13	-	.56	3.85E-06	1.06E-04
divalent inorganic cation homeostasis (GO:0072507)	483	41	73.06	-	.56	1.41E-04	2.61E-03
cellular calcium ion homeostasis (GO:0006874)	427	36	64.59	-	.56	2.92E-04	4.97E-03
calcium ion homeostasis (GO:0055074)	442	37	66.86	-	.55	2.12E-04	3.74E-03
regulation of cell adhesion (GO:0030155)	721	60	109.06	-	.55	1.15E-06	3.52E-05
cell part morphogenesis (GO:0032990)	532	44	80.47	-	.55	3.47E-05	7.53E-04
anatomical structure formation involved in morphogenesis (GO:0048646)	889	73	134.47	-	.54	3.27E-08	1.32E-06
cell morphogenesis (GO:0000902)	721	59	109.06	-	.54	6.51E-07	2.09E-05
regulation of small GTPase mediated signal transduction (GO:0051056)	330	27	49.92	-	.54	1.15E-03	1.61E-02
regulation of ERK1 and ERK2 cascade (GO:0070372)	295	24	44.62	-	.54	1.93E-03	2.53E-02
regulation of nervous system development (GO:0051960)	443	36	67.01	-	.54	1.21E-04	2.26E-03
inflammatory response (GO:0006954)	517	42	78.20	-	.54	2.68E-05	6.00E-04
positive regulation of transcription by RNA polymerase II (GO:0045944)	1215	98	183.79	-	.53	2.56E-11	1.56E-09
muscle organ development (GO:0007517)	286	23	43.26	-	.53	2.16E-03	2.78E-02
vasculature development (GO:0001944)	525	42	79.41	-	.53	1.71E-05	3.98E-04
plasma membrane bounded cell projection morphogenesis (GO:0120039)	506	40	76.54	-	.52	1.62E-05	3.81E-04
cell projection morphogenesis (GO:0048858)	510	40	77.14	-	.52	1.28E-05	3.15E-04
keratinocyte differentiation (GO:0030216)	269	21	40.69	-	.52	2.08E-03	2.70E-02
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	258	20	39.03	-	.51	2.27E-03	2.91E-02
regulation of angiogenesis (GO:0045765)	284	22	42.96	-	.51	1.16E-03	1.63E-02
tube development (GO:0035295)	860	66	130.09	-	.51	3.92E-09	1.88E-07
regulation of vasculature development (GO:1901342)	287	22	43.41	-	.51	9.09E-04	1.33E-02
blood vessel development (GO:0001568)	502	38	75.93	-	.50	5.91E-06	1.57E-04
neuron projection morphogenesis (GO:0048812)	502	38	75.93	-	.50	5.91E-06	1.57E-04
localization of cell (GO:0051674)	1112	84	168.21	-	.50	5.63E-12	3.75E-10
cell motility (GO:0048870)	1112	84	168.21	-	.50	5.63E-12	3.74E-10
negative regulation of developmental process (GO:0051093)	887	67	134.17	-	.50	1.06E-09	5.51E-08
keratinization (GO:0031424)	226	17	34.19	-	.50	2.96E-03	3.62E-02
regulation of blood circulation (GO:1903522)	293	22	44.32	-	.50	7.26E-04	1.11E-02
ear development (GO:0043583)	227	17	34.34	-	.50	2.98E-03	3.64E-02
negative regulation of cell adhesion (GO:0007162)	284	21	42.96	-	.49	6.07E-04	9.45E-03
negative regulation of cell differentiation (GO:0045596)	643	47	97.26	-	.48	8.84E-08	3.27E-06
mesenchyme development (GO:0060485)	219	16	33.13	-	.48	2.52E-03	3.16E-02
animal organ morphogenesis (GO:0009887)	972	71	147.03	-	.48	2.94E-11	1.77E-09
locomotion (GO:0040011)	1346	97	203.60	-	.48	1.12E-15	1.06E-13
regulation of leukocyte activation (GO:0002694)	625	45	94.54	-	.48	8.05E-08	3.01E-06
negative regulation of response to external stimulus (GO:0032102)	557	40	84.25	-	.47	4.19E-07	1.41E-05
regulation of epithelial cell proliferation (GO:0050678)	349	25	52.79	-	.47	7.59E-05	1.50E-03
leukocyte differentiation (GO:0002521)	350	25	52.94	-	.47	7.65E-05	1.51E-03
angiogenesis (GO:0001525)	323	23	48.86	-	.47	1.49E-04	2.75E-03
sensory organ morphogenesis (GO:0090596)	267	19	40.39	-	.47	5.54E-04	8.74E-03
negative regulation of defense response (GO:0031348)	398	28	60.20	-	.47	1.71E-05	3.99E-04
cell morphogenesis involved in neuron differentiation (GO:0048667)	456	32	68.98	-	.46	3.55E-06	9.84E-05
heart morphogenesis (GO:0003007)	244	17	36.91	-	.46	8.40E-04	1.25E-02
regulation of Ras protein signal transduction (GO:0046578)	201	14	30.40	-	.46	2.27E-03	2.91E-02
axonogenesis (GO:0007409)	389	27	58.84	-	.46	1.40E-05	3.37E-04
regulation of cell activation (GO:0050865)	667	46	100.89	-	.46	7.42E-09	3.35E-07
axon development (GO:0061564)	423	29	63.98	-	.45	4.32E-06	1.18E-04
second-messenger-mediated signaling (GO:0019932)	351	24	53.09	-	.45	2.90E-05	6.44E-04
blood vessel morphogenesis (GO:0048514)	415	28	62.77	-	.45	4.69E-06	1.27E-04
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	208	14	31.46	-	.44	1.34E-03	1.85E-02
positive regulation of cell adhesion (GO:0045785)	431	29	65.19	-	.44	2.56E-06	7.29E-05
regulation of lymphocyte activation (GO:0051249)	536	36	81.08	-	.44	1.17E-07	4.25E-06
regulation of inflammatory response (GO:0050727)	551	37	83.35	-	.44	8.51E-08	3.17E-06
regulation of leukocyte differentiation (GO:1902105)	285	19	43.11	-	.44	1.52E-04	2.79E-03
defense response to bacterium (GO:0042742)	347	23	52.49	-	.44	2.42E-05	5.47E-04
regulation of T cell activation (GO:0050863)	333	22	50.37	-	.44	3.34E-05	7.31E-04
positive regulation of leukocyte activation (GO:0002696)	425	28	64.29	-	.44	2.11E-06	6.12E-05
cell migration (GO:0016477)	977	64	147.78	-	.43	1.14E-13	8.96E-12
skeletal system morphogenesis (GO:0048705)	229	15	34.64	-	.43	5.59E-04	8.79E-03
regulation of cell junction assembly (GO:1901888)	199	13	30.10	-	.43	1.43E-03	1.96E-02
cell morphogenesis involved in differentiation (GO:0000904)	568	37	85.92	-	.43	2.24E-08	9.23E-07
nervous system process (GO:0050877)	1403	91	212.22	-	.43	1.37E-19	1.49E-17
positive regulation of cell activation (GO:0050867)	436	28	65.95	-	.42	7.04E-07	2.25E-05
embryonic organ development (GO:0048568)	454	29	68.67	-	.42	3.88E-07	1.31E-05
leukocyte migration (GO:0050900)	381	24	57.63	-	.42	2.55E-06	7.27E-05
regulation of cell-cell adhesion (GO:0022407)	433	27	65.50	-	.41	4.25E-07	1.42E-05
regulation of signaling receptor activity (GO:0010469)	177	11	26.77	-	.41	1.58E-03	2.15E-02
regulation of leukocyte cell-cell adhesion (GO:1903037)	323	20	48.86	-	.41	1.21E-05	2.99E-04
tube morphogenesis (GO:0035239)	664	41	100.44	-	.41	1.67E-10	9.59E-09
lymphocyte mediated immunity (GO:0002449)	261	16	39.48	-	.41	1.04E-04	1.97E-03
regulation of T cell differentiation (GO:0045580)	147	9	22.24	-	.40	4.08E-03	4.71E-02
positive regulation of cell-cell adhesion (GO:0022409)	280	17	42.35	-	.40	4.20E-05	8.99E-04
positive regulation of lymphocyte activation (GO:0051251)	380	23	57.48	-	.40	1.55E-06	4.62E-05
chemotaxis (GO:0006935)	548	33	82.89	-	.40	3.78E-09	1.85E-07
positive regulation of T cell activation (GO:0050870)	216	13	32.67	-	.40	3.57E-04	5.93E-03
taxis (GO:0042330)	550	33	83.20	-	.40	3.87E-09	1.88E-07
embryonic morphogenesis (GO:0048598)	585	35	88.49	-	.40	8.54E-10	4.49E-08
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	236	14	35.70	-	.39	1.46E-04	2.70E-03
multicellular organismal signaling (GO:0035637)	137	8	20.72	-	.39	4.26E-03	4.90E-02
negative regulation of immune system process (GO:0002683)	587	34	88.79	-	.38	3.80E-10	2.09E-08
extracellular matrix organization (GO:0030198)	363	21	54.91	-	.38	9.07E-07	2.81E-05
extracellular structure organization (GO:0043062)	364	21	55.06	-	.38	9.07E-07	2.81E-05
regulation of neuron differentiation (GO:0045664)	191	11	28.89	-	.38	5.02E-04	8.00E-03
negative regulation of neurogenesis (GO:0050768)	140	8	21.18	-	.38	3.17E-03	3.84E-02
lymphocyte differentiation (GO:0030098)	246	14	37.21	-	.38	6.13E-05	1.26E-03
detection of stimulus (GO:0051606)	712	40	107.70	-	.37	1.29E-12	9.27E-11
regulation of epithelial cell differentiation (GO:0030856)	144	8	21.78	-	.37	2.37E-03	3.00E-02
regulation of B cell activation (GO:0050864)	217	12	32.82	-	.37	1.13E-04	2.12E-03
negative regulation of nervous system development (GO:0051961)	146	8	22.08	-	.36	1.74E-03	2.30E-02
tissue morphogenesis (GO:0048729)	550	30	83.20	-	.36	2.16E-10	1.23E-08
positive regulation of epithelial cell proliferation (GO:0050679)	202	11	30.56	-	.36	2.10E-04	3.70E-03
determination of bilateral symmetry (GO:0009855)	129	7	19.51	-	.36	3.22E-03	3.90E-02
phagocytosis, engulfment (GO:0006911)	130	7	19.66	-	.36	3.24E-03	3.92E-02
specification of symmetry (GO:0009799)	130	7	19.66	-	.36	3.24E-03	3.92E-02
sensory perception (GO:0007600)	981	52	148.39	-	.35	1.92E-18	2.03E-16
connective tissue development (GO:0061448)	209	11	31.61	-	.35	1.16E-04	2.19E-03
positive regulation of B cell activation (GO:0050871)	171	9	25.87	-	.35	5.20E-04	8.25E-03
central nervous system neuron differentiation (GO:0021953)	193	10	29.19	-	.34	1.52E-04	2.79E-03
synapse organization (GO:0050808)	273	14	41.29	-	.34	5.71E-06	1.52E-04
neuron projection guidance (GO:0097485)	278	14	42.05	-	.33	3.01E-06	8.45E-05
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	219	11	33.13	-	.33	4.68E-05	9.87E-04
morphogenesis of an epithelium (GO:0002009)	440	22	66.56	-	.33	2.24E-09	1.13E-07
limb development (GO:0060173)	181	9	27.38	-	.33	2.07E-04	3.67E-03
appendage development (GO:0048736)	181	9	27.38	-	.33	2.07E-04	3.67E-03
regulation of cytosolic calcium ion concentration (GO:0051480)	322	16	48.71	-	.33	3.66E-07	1.24E-05
neural tube development (GO:0021915)	162	8	24.50	-	.33	3.72E-04	6.15E-03
embryonic organ morphogenesis (GO:0048562)	304	15	45.98	-	.33	6.56E-07	2.11E-05
regulation of interleukin-6 production (GO:0032675)	142	7	21.48	-	.33	9.33E-04	1.36E-02
regulation of myeloid leukocyte differentiation (GO:0002761)	122	6	18.45	-	.33	2.36E-03	2.99E-02
cell junction organization (GO:0034330)	491	24	74.27	-	.32	1.46E-10	8.46E-09
determination of left/right symmetry (GO:0007368)	123	6	18.61	-	.32	2.38E-03	3.01E-02
negative regulation of immune response (GO:0050777)	349	17	52.79	-	.32	8.00E-08	3.00E-06
regulation of blood vessel diameter (GO:0097746)	144	7	21.78	-	.32	9.55E-04	1.39E-02
regulation of tube diameter (GO:0035296)	144	7	21.78	-	.32	9.55E-04	1.39E-02
regulation of tube size (GO:0035150)	145	7	21.93	-	.32	6.80E-04	1.05E-02
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	270	13	40.84	-	.32	2.13E-06	6.14E-05
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	250	12	37.82	-	.32	5.25E-06	1.41E-04
negative regulation of cell-cell adhesion (GO:0022408)	188	9	28.44	-	.32	1.12E-04	2.12E-03
cardiac ventricle development (GO:0003231)	127	6	19.21	-	.31	1.75E-03	2.32E-02
axon guidance (GO:0007411)	277	13	41.90	-	.31	1.13E-06	3.46E-05
limb morphogenesis (GO:0035108)	151	7	22.84	-	.31	5.14E-04	8.17E-03
appendage morphogenesis (GO:0035107)	151	7	22.84	-	.31	5.14E-04	8.16E-03
positive regulation of cytosolic calcium ion concentration (GO:0007204)	283	13	42.81	-	.30	5.99E-07	1.94E-05
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	132	6	19.97	-	.30	9.02E-04	1.33E-02
branching morphogenesis of an epithelial tube (GO:0048754)	132	6	19.97	-	.30	9.02E-04	1.32E-02
epithelial tube morphogenesis (GO:0060562)	309	14	46.74	-	.30	1.85E-07	6.57E-06
positive regulation of leukocyte differentiation (GO:1902107)	156	7	23.60	-	.30	2.61E-04	4.49E-03
positive regulation of hemopoiesis (GO:1903708)	156	7	23.60	-	.30	2.61E-04	4.48E-03
negative regulation of lymphocyte activation (GO:0051250)	157	7	23.75	-	.29	2.67E-04	4.56E-03
epithelial cell development (GO:0002064)	203	9	30.71	-	.29	2.22E-05	5.06E-04
cornification (GO:0070268)	113	5	17.09	-	.29	2.32E-03	2.97E-02
negative regulation of cell activation (GO:0050866)	208	9	31.46	-	.29	1.15E-05	2.85E-04
negative regulation of inflammatory response (GO:0050728)	324	14	49.01	-	.29	3.57E-08	1.43E-06
cell junction assembly (GO:0034329)	279	12	42.20	-	.28	2.92E-07	1.01E-05
cell-cell junction organization (GO:0045216)	187	8	28.29	-	.28	4.06E-05	8.70E-04
negative regulation of leukocyte activation (GO:0002695)	187	8	28.29	-	.28	4.06E-05	8.68E-04
regulation of biomineralization (GO:0110149)	94	4	14.22	-	.28	4.18E-03	4.81E-02
cell-substrate adhesion (GO:0031589)	188	8	28.44	-	.28	2.83E-05	6.31E-04
endothelium development (GO:0003158)	95	4	14.37	-	.28	4.19E-03	4.82E-02
anterior/posterior pattern specification (GO:0009952)	215	9	32.52	-	.28	5.96E-06	1.58E-04
cell recognition (GO:0008037)	239	10	36.15	-	.28	1.76E-06	5.16E-05
negative regulation of T cell activation (GO:0050868)	121	5	18.30	-	.27	8.43E-04	1.26E-02
primary neural tube formation (GO:0014020)	97	4	14.67	-	.27	2.99E-03	3.64E-02
morphogenesis of embryonic epithelium (GO:0016331)	146	6	22.08	-	.27	2.46E-04	4.25E-03
positive regulation of leukocyte proliferation (GO:0070665)	150	6	22.69	-	.26	1.80E-04	3.22E-03
endocrine system development (GO:0035270)	126	5	19.06	-	.26	6.18E-04	9.60E-03
immunoglobulin mediated immune response (GO:0016064)	203	8	30.71	-	.26	7.75E-06	2.02E-04
cell-cell junction assembly (GO:0007043)	127	5	19.21	-	.26	4.30E-04	6.97E-03
nephron development (GO:0072006)	127	5	19.21	-	.26	4.30E-04	6.96E-03
cell-cell adhesion (GO:0098609)	510	20	77.14	-	.26	2.21E-13	1.69E-11
positive regulation of T cell proliferation (GO:0042102)	102	4	15.43	-	.26	2.15E-03	2.77E-02
B cell mediated immunity (GO:0019724)	206	8	31.16	-	.26	5.51E-06	1.47E-04
cell-matrix adhesion (GO:0007160)	129	5	19.51	-	.26	4.39E-04	7.08E-03
cyclic-nucleotide-mediated signaling (GO:0019935)	181	7	27.38	-	.26	1.83E-05	4.23E-04
cartilage development (GO:0051216)	156	6	23.60	-	.25	9.10E-05	1.78E-03
embryonic skeletal system development (GO:0048706)	131	5	19.82	-	.25	3.06E-04	5.19E-03
neural tube formation (GO:0001841)	105	4	15.88	-	.25	1.52E-03	2.08E-02
biological adhesion (GO:0022610)	953	36	144.15	-	.25	3.63E-25	5.44E-23
morphogenesis of a branching epithelium (GO:0061138)	159	6	24.05	-	.25	6.45E-05	1.31E-03
cell adhesion (GO:0007155)	947	35	143.25	-	.24	2.25E-25	3.44E-23
regulation of interferon-gamma production (GO:0032649)	109	4	16.49	-	.24	1.10E-03	1.57E-02
positive regulation of lymphocyte proliferation (GO:0050671)	138	5	20.87	-	.24	1.55E-04	2.85E-03
regulation of humoral immune response (GO:0002920)	138	5	20.87	-	.24	1.55E-04	2.84E-03
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	194	7	29.35	-	.24	4.70E-06	1.27E-04
positive regulation of mononuclear cell proliferation (GO:0032946)	139	5	21.03	-	.24	1.59E-04	2.89E-03
morphogenesis of a branching structure (GO:0001763)	168	6	25.41	-	.24	2.28E-05	5.16E-04
cardiac chamber development (GO:0003205)	171	6	25.87	-	.23	1.61E-05	3.78E-04
formation of primary germ layer (GO:0001704)	116	4	17.55	-	.23	5.63E-04	8.84E-03
artery development (GO:0060840)	88	3	13.31	-	.23	2.71E-03	3.35E-02
pattern specification process (GO:0007389)	443	15	67.01	-	.22	3.99E-13	3.03E-11
tube formation (GO:0035148)	148	5	22.39	-	.22	5.54E-05	1.15E-03
positive regulation of T cell differentiation (GO:0045582)	89	3	13.46	-	.22	2.78E-03	3.43E-02
axis specification (GO:0009798)	89	3	13.46	-	.22	2.78E-03	3.43E-02
humoral immune response (GO:0006959)	386	13	58.39	-	.22	1.27E-11	8.07E-10
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	90	3	13.61	-	.22	1.88E-03	2.47E-02
positive regulation of interleukin-6 production (GO:0032755)	91	3	13.76	-	.22	1.90E-03	2.49E-02
regionalization (GO:0003002)	335	11	50.67	-	.22	2.00E-10	1.14E-08
Unclassified (UNCLASSIFIED)	2839	91	429.44	-	.21	3.86E-87	4.08E-84
embryonic epithelial tube formation (GO:0001838)	125	4	18.91	-	.21	1.93E-04	3.43E-03
cell fate commitment (GO:0045165)	250	8	37.82	-	.21	4.34E-08	1.71E-06
regulation of neural precursor cell proliferation (GO:2000177)	96	3	14.52	-	.21	9.22E-04	1.35E-02
cardiac chamber morphogenesis (GO:0003206)	128	4	19.36	-	.21	1.35E-04	2.50E-03
cAMP-mediated signaling (GO:0019933)	160	5	24.20	-	.21	1.34E-05	3.22E-04
regulation of alpha-beta T cell activation (GO:0046634)	97	3	14.67	-	.20	9.24E-04	1.35E-02
kidney epithelium development (GO:0072073)	130	4	19.66	-	.20	9.18E-05	1.79E-03
nephron epithelium development (GO:0072009)	98	3	14.82	-	.20	9.43E-04	1.38E-02
embryonic skeletal system morphogenesis (GO:0048704)	98	3	14.82	-	.20	9.43E-04	1.38E-02
epithelial tube formation (GO:0072175)	133	4	20.12	-	.20	6.40E-05	1.31E-03
regulation of synapse assembly (GO:0051963)	101	3	15.28	-	.20	6.55E-04	1.01E-02
peptide cross-linking (GO:0018149)	101	3	15.28	-	.20	6.55E-04	1.01E-02
gland morphogenesis (GO:0022612)	101	3	15.28	-	.20	6.55E-04	1.01E-02
regulation of T cell proliferation (GO:0042129)	172	5	26.02	-	.19	3.17E-06	8.88E-05
regulation of leukocyte proliferation (GO:0070663)	244	7	36.91	-	.19	1.65E-08	6.96E-07
ameboidal-type cell migration (GO:0001667)	182	5	27.53	-	.18	1.08E-06	3.30E-05
adaptive immune response (GO:0002250)	628	17	94.99	-	.18	4.49E-21	5.35E-19
B cell differentiation (GO:0030183)	112	3	16.94	-	.18	1.49E-04	2.75E-03
regulation of lymphocyte proliferation (GO:0050670)	225	6	34.03	-	.18	3.79E-08	1.52E-06
G protein-coupled receptor signaling pathway (GO:0007186)	1323	35	200.12	-	.17	2.14E-44	8.07E-42
regulation of mononuclear cell proliferation (GO:0032944)	227	6	34.34	-	.17	2.58E-08	1.05E-06
dorsal/ventral pattern formation (GO:0009953)	81	2	12.25	-	.16	1.59E-03	2.15E-02
mesoderm development (GO:0007498)	123	3	18.61	-	.16	5.04E-05	1.06E-03
negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	208	5	31.46	-	.16	5.85E-08	2.23E-06
kidney morphogenesis (GO:0060993)	84	2	12.71	-	.16	1.09E-03	1.55E-02
regulation of interleukin-1 beta production (GO:0032651)	86	2	13.01	-	.15	7.27E-04	1.11E-02
regulation of inflammatory response to antigenic stimulus (GO:0002861)	221	5	33.43	-	.15	1.35E-08	5.84E-07
positive regulation of neuron differentiation (GO:0045666)	90	2	13.61	-	.15	5.08E-04	8.09E-03
epithelial cell migration (GO:0010631)	91	2	13.76	-	.15	5.29E-04	8.37E-03
epithelium migration (GO:0090132)	94	2	14.22	-	.14	3.60E-04	5.98E-03
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	99	2	14.98	-	.13	1.61E-04	2.92E-03
synapse assembly (GO:0007416)	100	2	15.13	-	.13	1.67E-04	3.00E-03
positive regulation of cell junction assembly (GO:1901890)	105	2	15.88	-	.13	7.45E-05	1.47E-03
regulation of Notch signaling pathway (GO:0008593)	106	2	16.03	-	.12	7.69E-05	1.52E-03
neuropeptide signaling pathway (GO:0007218)	109	2	16.49	-	.12	5.21E-05	1.09E-03
detection of stimulus involved in sensory perception (GO:0050906)	550	10	83.20	-	.12	2.90E-22	3.74E-20
regulation of complement activation (GO:0030449)	117	2	17.70	-	.11	1.58E-05	3.72E-04
sprouting angiogenesis (GO:0002040)	59	1	8.92	-	.11	3.55E-03	4.25E-02
mammary gland epithelium development (GO:0061180)	59	1	8.92	-	.11	3.55E-03	4.24E-02
positive regulation of protein tyrosine kinase activity (GO:0061098)	59	1	8.92	-	.11	3.55E-03	4.24E-02
O-glycan processing (GO:0016266)	61	1	9.23	-	.11	3.76E-03	4.44E-02
SMAD protein signal transduction (GO:0060395)	62	1	9.38	-	.11	2.40E-03	3.03E-02
artery morphogenesis (GO:0048844)	63	1	9.53	-	.10	2.43E-03	3.06E-02
forebrain generation of neurons (GO:0021872)	64	1	9.68	-	.10	2.52E-03	3.16E-02
detection of chemical stimulus (GO:0009593)	521	8	78.81	-	.10	2.16E-22	2.83E-20
positive regulation of synapse assembly (GO:0051965)	66	1	9.98	-	.10	1.63E-03	2.21E-02
neuron fate commitment (GO:0048663)	66	1	9.98	-	.10	1.63E-03	2.20E-02
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	137	2	20.72	-	.10	1.60E-06	4.72E-05
chondrocyte differentiation (GO:0002062)	70	1	10.59	-	.09	1.14E-03	1.61E-02
ventricular septum development (GO:0003281)	71	1	10.74	-	.09	7.30E-04	1.11E-02
outflow tract morphogenesis (GO:0003151)	72	1	10.89	-	.09	7.37E-04	1.12E-02
opsonization (GO:0008228)	73	1	11.04	-	.09	7.62E-04	1.15E-02
smoothened signaling pathway (GO:0007224)	75	1	11.34	-	.09	4.94E-04	7.91E-03
sensory perception of chemical stimulus (GO:0007606)	538	7	81.38	-	.09	1.94E-24	2.74E-22
nephron tubule development (GO:0072080)	77	1	11.65	-	.09	3.30E-04	5.53E-03
chemokine-mediated signaling pathway (GO:0070098)	79	1	11.95	-	.08	3.42E-04	5.70E-03
renal tubule development (GO:0061326)	80	1	12.10	-	.08	2.21E-04	3.87E-03
ureteric bud development (GO:0001657)	85	1	12.86	-	.08	1.53E-04	2.81E-03
mesonephric tubule development (GO:0072164)	86	1	13.01	-	.08	9.95E-05	1.92E-03
mesonephric epithelium development (GO:0072163)	86	1	13.01	-	.08	9.95E-05	1.92E-03
cell fate specification (GO:0001708)	87	1	13.16	-	.08	9.95E-05	1.91E-03
cellular response to chemokine (GO:1990869)	89	1	13.46	-	.07	1.08E-04	2.05E-03
response to chemokine (GO:1990868)	89	1	13.46	-	.07	1.08E-04	2.04E-03
mesonephros development (GO:0001823)	90	1	13.61	-	.07	6.66E-05	1.35E-03
cardiac septum development (GO:0003279)	109	1	16.49	-	.06	6.02E-06	1.60E-04
detection of chemical stimulus involved in sensory perception (GO:0050907)	485	4	73.36	-	.05	1.26E-24	1.80E-22
regulation of osteoblast differentiation (GO:0045667)	122	1	18.45	-	.05	1.24E-06	3.75E-05
B cell receptor signaling pathway (GO:0050853)	132	1	19.97	-	.05	2.29E-07	8.05E-06
sensory perception of smell (GO:0007608)	466	2	70.49	-	.03	5.99E-26	9.80E-24
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	256	1	38.72	-	.03	1.03E-14	8.98E-13
regulation of acute inflammatory response (GO:0002673)	49	0	7.41	-	 < 0.01	2.12E-03	2.75E-02
cardiac septum morphogenesis (GO:0060411)	73	0	11.04	-	 < 0.01	7.07E-05	1.41E-03
complement activation, classical pathway (GO:0006958)	161	0	24.35	-	 < 0.01	2.06E-10	1.18E-08
complement activation (GO:0006956)	177	0	26.77	-	 < 0.01	2.56E-11	1.55E-09
phagocytosis, recognition (GO:0006910)	104	0	15.73	-	 < 0.01	6.36E-07	2.05E-05
positive regulation of osteoblast differentiation (GO:0045669)	62	0	9.38	-	 < 0.01	2.40E-04	4.16E-03
negative regulation of osteoblast differentiation (GO:0045668)	48	0	7.26	-	 < 0.01	2.04E-03	2.65E-02
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	166	0	25.11	-	 < 0.01	1.48E-10	8.53E-09
regulation of vasoconstriction (GO:0019229)	62	0	9.38	-	 < 0.01	2.40E-04	4.15E-03
ventral spinal cord development (GO:0021517)	50	0	7.56	-	 < 0.01	1.32E-03	1.83E-02
cell differentiation in spinal cord (GO:0021515)	58	0	8.77	-	 < 0.01	5.91E-04	9.22E-03
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	167	0	25.26	-	 < 0.01	8.84E-11	5.20E-09
mesonephric tubule morphogenesis (GO:0072171)	54	0	8.17	-	 < 0.01	8.68E-04	1.29E-02
negative regulation of mononuclear cell proliferation (GO:0032945)	86	0	13.01	-	 < 0.01	8.06E-06	2.09E-04
nephron epithelium morphogenesis (GO:0072088)	66	0	9.98	-	 < 0.01	1.58E-04	2.88E-03
neural crest cell migration (GO:0001755)	54	0	8.17	-	 < 0.01	8.68E-04	1.28E-02
nephron tubule morphogenesis (GO:0072078)	64	0	9.68	-	 < 0.01	2.52E-04	4.34E-03
mesoderm formation (GO:0001707)	69	0	10.44	-	 < 0.01	1.03E-04	1.98E-03
nephron morphogenesis (GO:0072028)	67	0	10.13	-	 < 0.01	1.65E-04	2.99E-03
positive regulation of interleukin-1 beta production (GO:0032731)	54	0	8.17	-	 < 0.01	8.68E-04	1.28E-02
membrane depolarization (GO:0051899)	52	0	7.87	-	 < 0.01	1.39E-03	1.91E-02
morphogenesis of an epithelial sheet (GO:0002011)	51	0	7.71	-	 < 0.01	1.33E-03	1.84E-02
response to progesterone (GO:0032570)	48	0	7.26	-	 < 0.01	2.04E-03	2.65E-02
negative regulation of leukocyte proliferation (GO:0070664)	92	0	13.92	-	 < 0.01	3.46E-06	9.60E-05
negative chemotaxis (GO:0050919)	46	0	6.96	-	 < 0.01	3.26E-03	3.92E-02
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	440	0	66.56	-	 < 0.01	1.42E-27	2.65E-25
digestive tract morphogenesis (GO:0048546)	49	0	7.41	-	 < 0.01	2.12E-03	2.74E-02
autonomic nervous system development (GO:0048483)	47	0	7.11	-	 < 0.01	2.02E-03	2.63E-02
negative regulation of lymphocyte proliferation (GO:0050672)	85	0	12.86	-	 < 0.01	1.30E-05	3.18E-04
mesoderm morphogenesis (GO:0048332)	71	0	10.74	-	 < 0.01	6.71E-05	1.35E-03
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	48	0	7.26	-	 < 0.01	2.04E-03	2.65E-02
renal tubule morphogenesis (GO:0061333)	67	0	10.13	-	 < 0.01	1.65E-04	2.98E-03
negative regulation of T cell proliferation (GO:0042130)	69	0	10.44	-	 < 0.01	1.03E-04	1.98E-03
ureteric bud morphogenesis (GO:0060675)	53	0	8.02	-	 < 0.01	8.60E-04	1.28E-02
neuron recognition (GO:0008038)	49	0	7.41	-	 < 0.01	2.12E-03	2.74E-02
